Top ▲

GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

The IUPHAR/BPS Guide to PHARMACOLOGY complete ligand list

Click here for help
Synthetic, semi-synthetic and natural peptides encoded in genomes other than human, rat and mouse (including oligopeptides and cyclic peptides).
Download as CSV

A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

Ligand name ID Synonyms
A Back to top
A-71378 894 A 71378, A71378
A-71623 858 A 71623, A71623, L-phenylalaninamide
A-71915 4856 A 71915, A71915, H-3048
A8Δ71-73 5780
abaloparatide Approved drug 8299 BA058, Tymlos®
abarelix Approved drug 1188 Plenaxis®, PPI 149, R 3827
abatacept Approved drug Immunopharmacology Ligand 6891 BMS-188667, CTLA4-IgG4m, Orencia®, RG-1046, RG-2077
A13:B7-24-GG 14153
A(4-24)(B7-24)H2 8346 A(4-24)(B7-24)H2 relaxin
A(4-24)(B7-24)H2 chain A 8347 A(4-24)H2 relaxin
A(4-24)(B7-24)H2 chain B 8348 (B7-24)H2 relaxin
abicipar pegol 8371 AGN-150998, MP0112
ABS-201 5308 ABS 201, ABS201, HPI-201, HPI201, KK13
ABS-212 5307 ABS 212, ABS212
Abz-Ser-Pro-Tyr(NO2)-OH 5132 o-aminobenzoyl-Ser-Pro-Tyr(NO2)-OH, TBC5182
AC-178,335 2065 AC 178335
AC187 689 AC 187, AC-187, acetyl-(Asn30,Tyr32)-calcitonin8-32, salmon calcitonin (8-32) reduced
Ac-c[Cys-Glu-His-D-Phe-Arg-Trp-D-Cys]-Pro-Pro-Lys-Asp-NH2 1342
Ac-[13C,15N]PGP Ligand is labelled Ligand is radioactive 12599
[Ac-D-2Nal1,D4CPA2,D-3Pal3,6,Leu8, D-Ala10]GnRH-II 5583
Ac-GRP-(20-26)-methylester 625 N-acetyl-GRP-(20-26)-ethylester
[Ac-His1]PACAP-27 2263 [Ac-His1]pituitary adenylate cyclase activating polypeptide-27
[125I][Ac-His1]PACAP-27 Ligand is labelled Ligand is radioactive 2260 [125I]-[Ac-His1]pituitary adenylate cyclase activating polypeptide-27
Ac-hMCH-(6-16)-NH2 1290 hAc-MCH(6-16)-NH2, human Ac-MCH6-16-NH2
A(Δ10/15C)INSL3 8332
aclerastide 8300 DSC-127, DSC127, NorLeu3-A(1-7)
Ac-Lys-[MeAla6,Leu8,des-Arg9]bradykinin 651 N-acetylated-[Lys,MeAla6,Leu8,des-Arg9]bradykinin, Ac-[MeAla6,Leu8,des-Arg9]kallidin
AcPhe-Orn-Pro-D-Cha-Trp-Arg 3853 AcF[OP-D-Cha-Wr]
Ac-Phe-Trp-Ala-His(τBZL)-Nip-Gly-Arg-NH2 6191
Ac-RHYPLWR 8380
Ac-RYYRIK-NH2 1679
Ac-RYYRWK-NH2 1680
Ac-SDKP Immunopharmacology Ligand 10060 goralatide, seraspenide
A(C10/15S)INSL3 8331
ACTH-(11-24) 1332 ACTH (11-24), adrenocorticotropic hormone (11-24)
ACTH-(1-24) 1330 ACTH (1-24), adrenocorticotropic hormone (1-24)
[125I]ACTH-(1-24) Ligand is labelled Ligand is radioactive 3767 [125I]-ACTH(1-24), [125I]-adrenocorticotropin(1-24)
[Ac-Tyr1, D-Arg2]GHRH-(1-29)-NH2 (human) 1125
adaptavir 11692 D-Ala-peptide T-amide, DAPTA
[125I]adrenomedullin Ligand is labelled Ligand is radioactive 3768 [125I]-adrenomedullin, [125I]-AM
adrenomedullin-(22-52) (human) 706 AM (22-52), AM-(22-52) (human), human adrenomedullin (22-52)
adrenomedullin-(11-50) (rat) 704 AM (11-50), rat adrenomedullin (11-50)
adrenomedullin-(20-50) (rat) 705 rat adrenomedullin (20-50)
AF12198 Immunopharmacology Ligand 4861 AF 12198, AF-12198
A(4-24)(F23A)H2 8349
afamelanotide Approved drug 1324 α-NDP-MSH, [Nle4,dPhe7]α-MSH, CUV-1647, CUV1647, NDP-MSH, Scenesse®
aflibercept Approved drug 6786 AVE0005, Eylea®, VEGF Trap, Zaltrap®, ziv-aflibercept
AFT-II 2613 neurotoxin-2, Toxin AFII, Toxin AFT-II
ω-agatoxin IIIA 2528 omega-Aga-IIIA, Omega-agatoxin-Aa3a
ω-agatoxin IVA 2529 omega-Aga-IVA, Omega-agatoxin-Aa4a
ω-agatoxin IVB 2530 Omega-agatoxin-Aa4b
A(10-24)INSL3 8330
A(9-26)INSL3 8329
AL-78898A Immunopharmacology Ligand 9219 4(1MeW), POT-4
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-34)-NH2 5573 [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-hPTH 1-34-NH2, M-PTH(1-34)
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-21)-NH2 (human) 5575 [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]hPTH-(1-21)-NH2, [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-PTH 1-21-NH2 (human), M-PTH(1-21)
[Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]PTH-(1-28)-NH2 (human) 5574 [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-hPTH 1-28-NH2, [Ala1,12,Aib3,Gln10,hArg11,Trp14,Arg19]-PTH 1-28-NH2 (human), M-PTH(1-28)
[Ala1,12,Aib3,Gln10,hArg11,Trp14]PTH-(1-14)-NH2 5576 [Ala1,12,Aib3,Gln10,hArg11,Trp14]-hPTH 1-14-NH2, [Ala1,12,Aib3,Gln10,hArg11,Trp14]-PTH 1-14-NH2 (human), M-PTH(1-14)
[Ala31,Aib32]NPY 1560
[Ala31,Aib32]NPY (pig) 1522
[Ala11, D-Leu15]orexin-B 1700
[Ala6, D-Trp8]galanin-(1-15)-ol 6146
[Ala1,3,11,15]ET-1 3837 [Ala1,3,11,15]endothelin-1
[125I][Ala1,3,11,15]ET-1 Ligand is labelled Ligand is radioactive 3760 [125I]-[Ala1,3,11,15]endothelin-1, [125I][Ala1,3,11,15]endothelin-1
alafosfalin PDB Ligand 9503 alaphosphin
[2Ala]-galparan 6098
β-Ala-Lys-AMCA Ligand is labelled 9501 β-alanyl-lysyl-N-7-amino-4-methylcoumarin-3-acetic acid, Beta-Ala-Lys-N(epsilon)-AMCA
[βAla8]neurokinin A-(4-10) 2112 [βAla8]neurokinin A (4-10)
alarelin 9342
[Ala11,22,28]VIP 2278 [Ala11,22,28]vasoactive intestinal peptide
albiglutide Approved drug 7386 Eperzan®, GSK716155, Tanzeum®
albutensin A 10226
aldafermin 11546 M70, NGM-282, NGM282
alefacept Approved drug Immunopharmacology Ligand 6787 Amevive®, BG 9273, BG 9712, BG-9273, BG-9712, Lfa3Tip
alglucosidase alfa Approved drug 7561 Lumizyme®, Myozyme®, rhGAA
ALM201 11485
alpha1-proteinase inhibitor Approved drug 7487 A1AT, A1PI, alpha 1-antitrypsin, Aralast®, Prolastin®, serum trypsin inhibitor
AlprolixTM Approved drug 7373
alunacedase alfa 11320 APN01, GSK-2586881, GSK2586881, rhsACE2
ALX40-4C 607 ALX 40-4C, N-alpha-acetyl-nona-D-arginine amide acetate
AM3 5635 DOTA-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-D-Trp-Lys-Thr-Cys)
AM-6120 Immunopharmacology Ligand 10119 AM6120, peptide 41 [PMID: 30346167]
amanitin 4632 α-amanitin
AMG3054 9587
AMT-101 Immunopharmacology Ligand 11645
AMY-101 11986 AMY101, Compstatin 40, Compstatin analog CP40, CP-40, peptide 14 [PMID: 22795972]
[125I]amylin Ligand is labelled Ligand is radioactive 3770 [125I]-BH-AMY, [125I]-Bolton Hunter amylin
amyloid β1-16 13243 Aβ(1-16), N-Aβ
anakinra Approved drug Immunopharmacology Ligand 6972 antril, Kineret®
analog 30 [PMID:18543899] 5647
analog 31 [PMID:18543899] 5648
analog 32 [PMID:18543899] 7763
analog 3 [PMID:18543899] 5646
analogue 13: B7-24 11918
anantin 4866
andexanet alfa Approved drug 7576 Andexxa®, coagulation factor Xa (recombinant), inactivated-zhzo, Ondexxya®, PRT064445, PRT4445, r-antidote
[125I]angiotensin-(1-7) (human, mouse, rat) Ligand is labelled Ligand is radioactive 5578 [125I]ang-(1-7)
[125I]ANP (human) Ligand is labelled Ligand is radioactive 4845 [125I]-ANP
antarelix 1189 D-23234, EP 24332
antisauvagine 931 [dPhe11,His12]Svg(11-40), antisauvagine-30
[125I]antisauvagine Ligand is labelled Ligand is radioactive 930
AP811 4870 AP 811, AP-811
apamin 2311
APB-R3 Immunopharmacology Ligand 13869
[125I]apelin-13 Ligand is labelled Ligand is radioactive 602
apelin-13(F13A) 5354
APETx-1 2609 Toxin APETx1
APETx2 4135
aponermin Approved drug 13293 Shaite® (China)
apraglutide 10685 CVQ1IAY2G6, FE 203799, FE203799
aprotinin  {Sp: Bovine} Approved drug 6570 basic protease inhibitor (BPI), BPTI, pancreatic trypsin inhibitor, Trasylol®
AR305352 7043
[Arg16]chicken secretin 3293 [R16]chicken secretin
arginine vasotocin 2169 AVT, [Arg8]vasotocin
[Arg14Lys15]N/OFQ 1689 [Arg14Lys15]nociceptin, [Arg14Lys15]nociceptin/orphanin FQ, [Arg14Lys15]orphanin FQ
[Arg19]PTH-(1-34) (human) 1792 [Arg19]-PTH 1-34 (human)
ARL-15849 859 AR-R 15849, ARL 15849XX, FPL 15849
ASIP [90-132 (L89Y)] 1327 agouti-signaling protein [90-132 (L89Y)], agouti-signaling protein[90-132 (L89Y)]
aspartame PDB Ligand 13899 Canderel®, NutraSweet®, SC18862
astressin 925
[125I]astressin Ligand is labelled Ligand is radioactive 924
astressin 2B 10335 Astressin2-B, astressin2-B, cyclo(31-34)[DPhe(11),His(12),C(alpha)MeLeu(13,39),Nle(17),Glu(31),Lys(34)]Ac-sauvagine(8-40), peptide 20 [PMID: 12361401]
[Asu7,23']β-ANP-(7-28) 4852 [Asu7,23']-β-ANP7-28
atacicept Immunopharmacology Ligand 9517 TACI-Fc, TACI-Ig
atosiban Approved drug 2213 Antocin®, d[D-Tyr(Et)2,Thr4,Orn8]vasotocin, d[D-Tyr(Et)2,Thr4]OVT, ORF22164, RWJ 22164, Tractocile®
ATX-II 2614 anemonia viridis toxin 2, Sea anemone toxin II (Anemonia sulcata), toxin ATX-II
aTyr 1940 8738 ATYR1940, HRS(1-506), Resolaris
AUNP-12 10117 Aur-012, Aurigene NP-12, Aurigene-012, compound #8 [WO2011161699A3]
Ava3 3855
Ava5 3856
[Ava9,10,Ava14,15]-Ac-hMCH6-16-NH2 1307 compound 30 [PMID:12009900]
avexitide 13444
aviptadil Approved drug 10891 Invicorp® (aviptadil + phentolamine), Vasoactive intestinal octacosapeptide
[3H]AVP (human, mouse, rat) Ligand is labelled Ligand is radioactive 2175 [3H]arginine vasopressin
AY77 9455 compound 14 [PMID: 26819675]
AYPGKF-NH2 4061 AY-NH2
azapro-3 Immunopharmacology Ligand 9221
 
B Back to top
B-10356 652
B1-27 11459 analog 2 [PMID: 32133341]
B-9430 653 B 9430, B9430, D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin
B-9858 654 B 9858, Lys-Lys-[Hyp3, Igl5, D-Igl7, Oic8]des-Arg9-BK
B-9958 655 B9958, des-Arg(9)-BK
balixafortide 11587 POL-6326, POL6326
barusiban 10890 C4.6,S1-cyclo[N-(3-sulfanylpropanoyl)-D-tryptophyl-L-isoleucyl-L-alloisoleucyl-L-asparaginyl-L-2-aminobutanoyl-N-methyl-L-ornithinol], FE 200 440, FE-200440
BASS antagonist 5644 BASS antagonist Analog 4
BAY 55-9837 2269
BAY86-7548 Ligand is labelled Ligand is radioactive 11260 [68Ga]D-Phe6, Stat13, Leu14 Bn(6-14), [68Ga]RM2, Ga-RM2
[125I]BAY 55-9837 Ligand is labelled Ligand is radioactive 2281
BBL-454 895 BBL 454, BBL454
BC-254 896 BC 254, BC254
BC-264 897 BC 264, BC264
Bc-III 2615 major neurotoxin BcIII
BCY15291 12820
[125I]BDNF (human) Ligand is labelled Ligand is radioactive 4846 [125I]-BDNF, [125I]-brain-derived neurotrophic factor
beinaglutide Approved drug 12863 Feisumei®
BeKm-1 2610 neurotoxin BeKm-1, potassium channel toxin γ-KTx 2.1
belatacept Approved drug Immunopharmacology Ligand 6892 BMS-224818, LEA29Y, Nulojix®
bempegaldesleukin Immunopharmacology Ligand 10659 NKTR-214, NKTR214
bevemipretide 13258 SBT-272, SBT272
bevifibatide Approved drug 13953 BAT-2094, batifiban, Beitaning, Betagrin®, Compound I [CN101085809A]
BgK 2551 Potassium channel toxin Bgk
[125I]BgK (W5Y / Y26F) Ligand is labelled Ligand is radioactive 2565
(B7-33)H2 9321
[125I]BH-MIT1 Ligand is labelled Ligand is radioactive 8522
[125I]BH-NMB (human, mouse, rat) Ligand is labelled Ligand is radioactive 3771 [125I]-BH-NMB, [125I]-Bolton Hunter neuromedin B
[125I]BH-[Sar9,Met(O2)11]SP Ligand is labelled Ligand is radioactive 3769 [125I]-BH-[Sar9,Met(O2)11]SP, [125I]-Bolton Hunter-[Sar9,Met(O2)11]substance P
[3H]BH-[Sar9,Met(O2)11]SP Ligand is labelled Ligand is radioactive 3811 [3H]-Bolton Hunter-[Sar9,Met(O2)11]substance P, [3H]-BH-[Sar9,Met(O2)11]SP
bihelical apoA-I mimetic peptide 5A Immunopharmacology Ligand 9183 5A peptide
BIM 23023 2032
BIM 23027 2033 BIM23027
BIM 23030 2034
BIM 23034 2035 DC 13-212
BIM 23050 2003 BIM-23050
BIM 23052 2004 BIM-23052, BIM23052, DC-(23-99)
BIM 23056 2036
BIM 23058 2068
BIM 23059 2037
BIM 23060 2038
BIM 23066 2039
BIM 23068 2040
BIM 23127 2162
BIM 23197 2041
BIM 23268 2083 BIM23268
BIM 23295 2069
BIM 23313 2084
BIM 23454 2026
BIM 23627 2027 H-5886, MW 1164
BIM28011 3857 [D-Ala2,Ala8,9,15,27,D-Arg29]hGHRH(1-29)NH2, BIM 28011
BIM 28163 1101 BIM-28163
[125I]BIM23027 Ligand is labelled Ligand is radioactive 3772 [125I]-BIM 23027, [125I]-BIM23027
BIO1211 6589 BIO 1211, BIO-1211
bivalirudin Approved drug 6470 Angiomax®
BJP-06-005-3 11401 compound 1 [PMID: 32483379], N-(chloroacetyl)-N-methyl-L-phenylalanyl-L-homoprolyl-L-tryptophyl-L-citrulline ethyl ester
[3H]BK (human, mouse, rat) Ligand is labelled Ligand is radioactive 3812 [3H]-BK, [3H]-bradykinin
blisibimod Immunopharmacology Ligand 9518 A-623, AGP3 peptibody, AMG 623, Fc-Agp-3
BM213 12513
BM221 12514
BmP09 14028
BMS-986238 Immunopharmacology Ligand 13877 BMS 986238, BMS986238
BmTx1 14026
BmTx2 14025
BOC-ATE 2042
BODIPY® TMR-NMU 3858
bombesin 616
BOP 12045 compound 2 [PMID: 24363056], compound 3 [PMID: 12033947], N-(Benzenesulfonyl)-L-prolyl-L-O-(1-pyrrolidinylcarbonyl)tyrosine
[Bpa1,Ile13]motilin (human) 1452
[Bpa6,Tyr10]secretin-27 (rat) Ligand is labelled Ligand is radioactive 1154
BP-CCL3 752 BP-LD78α, BP-MIP-1α, photoactivatable macrophage inflammatory protein-1α
BPTI-K15R/R17G 7897
BQ123 997 BQ 123, BQ-123
BQ 3020 3859 BQ-3020, BQ3020
[125I]BQ3020 Ligand is labelled Ligand is radioactive 1005 [125I]-BQ3020
[3H]BQ123 Ligand is labelled Ligand is radioactive 1003 [3H]-BQ123, [3H]cyc(DTrp-DAsp-Pro-DVal-Leu
bremelanotide Approved drug 10408 PT-141, PT141, Vyleesi®
B-R13HR H2 relaxin 14151 H2 B-R13HR
brimapitide Immunopharmacology Ligand 9101 AM-111, D-JNKI-1, XG-102
B-R13/17K H2 relaxin 4371 AT-001, B13/17K H2 relaxin
BT7480 Immunopharmacology Ligand 12060 BCY11863, BT-7480
bulevirtide Approved drug 12775 BLV, formerly Myrcludex B, Hepcludex®
α-bungarotoxin 3964
[125I]α-bungarotoxin Ligand is labelled Ligand is radioactive 3972
[3H]α-bungarotoxin Ligand is labelled Ligand is radioactive 3981
buserelin Approved drug 3860 buserelin acetate, HOE 766, HOE 766A, ICI 123215, Metrelef®, Suprefact®
[125I]buserelin Ligand is labelled Ligand is radioactive 1167 [125I]-buserelin
butantoxin 14031 α-KTx12.1
Bv8 5362 Bombina variegata protein
[Bz-Phe6]U-II (human) 2159 human [Bz-Phe6] urotensin-II
 
C Back to top
C089 5779
C21 7037
C3 1291
C7 3861 galanin(1-13)spantide
cagrilintide 13768 AM-833, AM833, analogue 23 [PMID: 34288673], NN0174-0833
C5a hexapeptide analogue 5768 Phe-Lys-Ala-dCha-Cha-dArg
[125I]C3a (human) Ligand is labelled Ligand is radioactive 3773 [125I]-C3a
[125I]C5a (human) Ligand is labelled Ligand is radioactive 3774 [125I]-C5a
calciseptine 4149
[125I]calcitonin Ligand is labelled Ligand is radioactive 3776 [125I]-calcitonin (Human), [125I]-CT (Human)
calcitonin-(8-32) (salmon) 690 CT (8-32) (salmon), CT-(8-32) (salmon), salmon calcitonin (8-32)
calcitonin (salmon) Approved drug 6973 CT (salmon), Miacalcin®
[125I]calcitonin (salmon) Ligand is labelled Ligand is radioactive 3777 [125I]-calcitonin (Salmon), [125I]-CT (Salmon)
calpeptin 11643 benzylcarbonyl-Leu-nLeu-H, N-benzyloxycarbonyl-L-leucyl-L-norleucinal
cANF4-23 4892 des[Gln18,Ser19,Gly20,Leu21,Gly22]ANP4ï¾–23-NH2
cangitoxin II 7568 cangitoxin-2, cangitoxin-II, CGTX-II
C5apep 11344
carbetocin Approved drug 11169 Pabal®
casoxin C 10224
[125I]cathepsin G (human) Ligand is labelled Ligand is radioactive 1017 [125I]cathepsin G
CB-182804 11003 CB-182,804, CB182804
CCK-58  {Sp: Dog} 862
[3H]CCK-8 (human, mouse, rat) Ligand is labelled Ligand is radioactive 4765 [3H]-CCK-8
[125I]CCL11 (human) Ligand is labelled Ligand is radioactive 794 [125I]eotaxin
[125I]CCL16 (human) Ligand is labelled Ligand is radioactive 1275 [125I]LEC
[125I]CCL17 (human) Ligand is labelled Ligand is radioactive 3652 [125I]TARC
[125I]CCL19 (human) Ligand is labelled Ligand is radioactive 3655 [125I]ELC
[125I]CCL1 (human) Ligand is labelled Ligand is radioactive 814 [125I]I-309, [125I]P500, [125I]TCA-3
[125I]CCL20 (human) Ligand is labelled Ligand is radioactive 3654 [125I]LARC, [125I]MIP-3α
[125I]CCL21 (human) Ligand is labelled Ligand is radioactive 3656 [125I]SLC
[125I]CCL25 (human) Ligand is labelled Ligand is radioactive 3657 [125I]TECK
[125I]CCL27 (human) Ligand is labelled Ligand is radioactive 3653 [125I]CTACK
[125I]CCL2 (human) Ligand is labelled Ligand is radioactive 762 [125I]MCAF, [125I]MCP-1, [125I]monocyte chemotactic protein-1
[125I]CCL3 (human) Ligand is labelled Ligand is radioactive 763 [125I]macrophage inflammatory protein-1α, [125I]MIP-1α
[125I]CCL4 (human) Ligand is labelled Ligand is radioactive 799 [125I]macrophage inflammatory protein-1β, [125I]MIP-1β
[125I]CCL5 (human) Ligand is labelled Ligand is radioactive 764 [125I]RANTES, [125I]regulated upon activation normal T cell expressed and secreted
[125I]CCL7 (human) Ligand is labelled Ligand is radioactive 765 [125I]MCP-3, [125I]monocyte chemotactic protein-3
[125I]CCL8 (human) Ligand is labelled Ligand is radioactive 766 [125I]MCP-2, [125I]monocyte chemotactic protein-2
[125I]CCL1 (mouse) Ligand is labelled Ligand is radioactive 5546
CCL20-SEAP(His)6 809 LARC fused with secreted alkaline phosphatase, LARC-SEAP(His)6, MIP-3α fused with secreted alkaline phosphatase
cenderitide 9066 CD-NP
cetrorelix Approved drug Immunopharmacology Ligand 1190 Cetrotide®, SB-075
[125I]cetrorelix Ligand is labelled Ligand is radioactive 1186
CGEN-856 7041 P61
CGEN-857 7040 P33
CGEN-855A 6241
CGP 23996 2005 CGP-23996, CGP23996
CGP42112 3944 CGP 42112, CGP 42112A
[125I]CGP 23996 Ligand is labelled Ligand is radioactive 2022
[125I]CGP42112 Ligand is labelled Ligand is radioactive 594 [125I]-CGP42112, Cgp 42112B, Cgp-42112A
[125I]αCGRP Ligand is labelled Ligand is radioactive 3766 [125I]-αcalcitonin gene-related peptide, [125I]-αCGRP
α-CGRP-(8-37) (human) 700 α-CGRP (8-37) (human), human α-calcitonin gene-related peptide (8-37)
[125I]αCGRP (mouse, rat) Ligand is labelled Ligand is radioactive 6567
α-CGRP-(8-37) (rat) 701 α-CGRP (8-37) (rat), rat α-calcitonin gene-related peptide (8-37)
CH 275 2006 CH-275, desAA1,2,5[D-Trp8,IAmp9]somatostatin-14
charybdotoxin 2328 ChTX, ChTX-Lql
charybdotoxin-GLU32 analog 2329 ChTX-GLU32
[Cha6]U-II-(4-11) 9439
chemerin C-terminal peptide 3422 bioactive chemerin peptide, chemerin 149-157, chemerin 9, chemerin-9
CHIPS 3724 chemotaxis inhibitory protein of S. aureus
CHIPS-(28-149) 5770 CHIPS28-149
[125I]CHIPS Ligand is labelled Ligand is radioactive 1027 [125I]chemotaxis inhibitory protein of S. aureus
[(CH2NH)4,5]secretin 3755 [ψ4,5]secretin
[125I]chorionic gonadotropin (human) Ligand is labelled Ligand is radioactive 3775 [125I]CG (human), [125I]-CG, [125I]-chorionic gonadotropin
ChTX-Lq2 14030
cibinetide Immunopharmacology Ligand 9677 ARA 290, ARA-290, PH-BSP, PHBSP
C12-iE-DAP 9508
CIGB-552 13896 CIGB552
cilengitide 6597 EMD-12192, EMD-121974
4-Cl-cinnamoyl-c[DCys-4Pal-DTrp-Orn-Val-Cys]-His-amide 2161
[125I]CNP (human) Ligand is labelled Ligand is radioactive 4847 [125I]-CNP
C2-NPY (pig) 1534
compound 54 11898
compound 6b [PMID: 24999562] 7927
compound 25c [PMID: 23747811] 11641
compound 3c [PMID: 30360354] Immunopharmacology Ligand 10591 [As(4-F)F4]-GHRP-6, azasulfuryl-p-fluorophenylalanine-4-[As(4-F)F4]-GHRP-6, H-His-D-Trp-Ala-(4-F)AsF-D-Phe-Lys-NH2
compound 5d [PMID: 25815150] 9008
compound 8d [PMID: 24999562] 7926
compound 1 [PMID: 25241924] 7801
compound 2 [PMID: 11375253] 1292
compound 3 [PMID: 16884309] 11640
compound 18-S4 [PMID: 31413801] 14157
compstatin Immunopharmacology Ligand 9218
conantokin-G 4161 conotoxin GV
concanavalin A 4162
conestat alfa Approved drug 7627 rhC1INH, Ruconest®
conkunitzin-S1 toxin 7758 conk-S1, Kunitz-type conkunitzin-S1
conopeptide Y-PI1 7742
α-conotoxin ArIB 4007
α-conotoxin AuIB 3973
ω-conotoxin CVIA 2531
ω-conotoxin CVIB 2532
ω-conotoxin CVIC 2533
ω-conotoxin CVID 2534 AM-336, AM336, CNSB004, leconotide
α-conotoxin GI 3983 G1
α-conotoxin-GIC 4009
μ-conotoxin GIIIA 2630 Geographutoxin I, GTx-I, Myotoxin I
ω-conotoxin GVIA 2535
α-conotoxin ImI 3965 α-CTx ImI
α-conotoxin MI 3999
α-conotoxin MII 3970
[125I]α-conotoxin MII Ligand is labelled Ligand is radioactive 3975
α-conotoxin MII [H9A, L15A] 4010
ω-conotoxin MVIIC 2537 ω-CTx-MVIIC, SNX-230
ω-conotoxin MVIID 2538 SNX-238
α-conotoxin PIA 3985
μ-conotoxin PIIIA 2631 μ-conotoxin P3.7
α-conotoxin PnIA 3982
α-conotoxin RgIA 4008
μ-conotoxin SmIIIA 7567
α-conotoxin TxIA 4011
consomatin Fj1 13681
contulakin-G 1575 CGX-1160
corticotropin-releasing factor  {Sp: Sheep} 913 CRF, corticoliberin, endorpholiberin
corticotropin zinc hydroxide Approved drug Immunopharmacology Ligand 6967
cosyntropin Approved drug 6965 Cortrosyn®
CPN-116 11490 peptide 6b [PMID: 24999562]
CPN-219 11491
CPN-223 11492 analogue 8 [PMID: 32721452]
CPN-267 10380 analogue 7b [PMID: 28548497], C-terminal core peptide derivative of neuromedin U, bearing (α-Me)Trp2, NMUR1 agonist C7b
[125I][cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP Ligand is labelled Ligand is radioactive 3921 [125I]-[cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP
CPS4 11603
[125I]CRF (ovine) Ligand is labelled Ligand is radioactive 915 [125I]corticotropin
crisantaspase Approved drug 7347 asparaginase, Elspar®, Enrylaze®, L-asparaginase, L-asparagine amidohydrolase
CTAP 1635
CTOP 1674 Ctop-NH2, CTOPA
[3H]CTOP Ligand is labelled Ligand is radioactive 12512
CTR-stimulating peptide  {Sp: Pig} 5369 calcitonin-receptor stimulating peptide, CRSP-1
CXCL12-(1-17) 846 CXCL12, 1-17, SDF-1, 1-17, stromal cell-derived factor-1, N-terminal fragment
CXCL12-(1-9) 847 CXCL12, 1-9
CXCL12-(1-9) dimer 848 CXCL12, 1-9 dimer, stromal cell-derived factor-1, N-terminal fragment dimer
CXCL122 (dimer) 8535
CXCL12H25R (monomer) 8534
[125I]CXCL10 (human) Ligand is labelled Ligand is radioactive 3660 [125I]IP-10
[125I]CXCL11 (human) Ligand is labelled Ligand is radioactive 3661 [125I]I-TAC
[125I]CXCL12α (human) Ligand is labelled Ligand is radioactive 849 [125I]SDF-1α (human), [125I]stromal cell-derived factor-1α
[125I]CXCL12β (human) Ligand is labelled Ligand is radioactive 850 [125I]SDF-1β (human), [125I]stromal cell-derived factor-1β
[125I]CXCL16 (human) Ligand is labelled Ligand is radioactive 3662
[125I]CXCL1 (human) Ligand is labelled Ligand is radioactive 3677 [125I]GROα
[125I]CXCL5 (human) Ligand is labelled Ligand is radioactive 3659 [125I]ENA-78
[125I]CXCL7 (human) Ligand is labelled Ligand is radioactive 3658 [125I]NAP-2
[125I]CXCL8 (human) Ligand is labelled Ligand is radioactive 822 [125I]IL-8, [125I]interleukin-8
[125I]CX3CL1 (human) Ligand is labelled Ligand is radioactive 3664 [125I]Fractalkine
[125I]CXCL13 (mouse) Ligand is labelled Ligand is radioactive 8631
Cy3B-NMU-8 Ligand is labelled 3863
cyclic INSL3 B-chain analogue 6 8333
cyclo apelin-12 (1-12) 6313 C1
cyclo apelin-12 (7-12) 6311 C4
cyclo(7-12) Des-AA1,2,5-[Glu7,D-Trp8,IAmp9,m-I-Tyr11,hhLys12]SRIF 2025
cyclohexylgriselimycin 13756 cyclohexyl-griselimycin
Cyclolinopeptide 1-Mso,3-Met-CL6 12467
cyclorelix 1191 D-23620
cyclosporin A Approved drug Immunopharmacology Ligand 1024 ciclosporin, cyclosporine, cyclosporine A, Ikervis® (opthalmic solution), Neoral®, Sandimmun®, Verkazia® (opthalmic solution)
cyclosporin H 1025
cyclotide kalata B1 13238
cyclourea apelin-12 (1-7) 6312 C3
[Cy5-Lys19]NPS Ligand is labelled 9166 Cy5-hNPS
[Cys(ACM)2,7]CGRP 698 [Cys(ACM)2,7]-calcitonin gene-related peptide, Cys(Acm)2,7-h-αCGRP
[Cys(Et)2,7]α-CGRP (human) 693 [cys(Et)2,7]α-calcitonin gene-related peptide (human)
 
D Back to top
D-23487 1180 D 23487
D-24710 1181 D 24710
ρ-Da1a 6663 toxin AdTx1
DADLE 1607 [D-Ala2, D-Leu5]-enkephalin, DADL, leucine enkephalin-2-alanine
[D-Ala7]-angiotensin(1-7) 6081 A-779, A779
(D-Ala11]bombesin 6179
[D-Ala2]deltorphin I 3838
[3H][D-Ala2]deltorphin I Ligand is labelled Ligand is radioactive 9065
[D-Ala2]deltorphin II 4060
[D-Ala2,F5,Phe4]dynorphin-(1-13)-NH2 1657 [D-Ala2,F5,Phe4]-dynorphin 1-13-NH2
[D-Ala2,F5,Phe4]dynorphin-(1-17)-NH2 1658 [D-Ala2,F5,Phe4]-dynorphin 1-17-NH2
D-Ala-Lys-AMCA Ligand is labelled 5421 (D)-Ala-(L)-Lys-Nε-AMCA, D-Ala-Lys-N(epsilon)-7-amino-4-methylcoumarin-3-acetic acid
DAMGO 1647 2-Ala-4-mephe-5-gly-enkephalin, DAGO, glyol
[3H]DAMGO Ligand is labelled Ligand is radioactive 3815 [3H]-DAMGO, [tyrosyl 3,5-3H]DAMGO
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P 1102
[D-Arg1,D-Trp7,9,Leu11]substance P 6184
[D-Arg8]inotocin 14174
davalintide 10684 DACRA
dAVP 2181 [deamino-Cys1]AVP, [deamino1]AVP, deamino-vasopressin
DAVP 2170 [D-Arg8]vasopressin, [D-Arg8]VP
dazodalibep Immunopharmacology Ligand 13453 MEDI-4920, MEDI4920, VIB 4920, VIB-4920, VIB4920
[D-Bpa5,Ile13]motilin (human) 1450
DC 23-60 2043
d[Cha4]AVP 2187 [1-deamino-4-cyclohexylalanine]AVP, [deamino-Cys1,Cha4]AVP
[3H]d[Cha4]AVP Ligand is labelled Ligand is radioactive 2227 [3H][1-deamino-4-cyclohexylalanine]AVP, [3H][deamino-Cys1,Cha4]AVP
d[Cha4,Dab8]VP 2186 [deamino-Cys1,Cha4,Dab8]vasopressin
d[Cha4]LVP 2188 [1-deamino-4-cyclohexylalanine]LVP, [deamino-Cys1,Cha4,Lys8]vasopressin
d(CH2)5[D-Ile2,Ile4,Ala-NH2]AVP 2215 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Ala-NH2]AVP
d(CH2)5[D-Ile2,Ile4,Ala-NH29]AVP 2214 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Ala-NH29]AVP, Pmp[D-Ile2,Ile4,Ala-NH2]AVP
d(CH2)5[D-Ile2,Ile4]AVP 2236 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4]AVP, d(CH2)5[D-Ile2,Ile4]VP
d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP 2235 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Tyr-NH29]AVP
[125I]d(CH2)5[D-Ile2,Ile4,Tyr-NH29]AVP Ligand is labelled Ligand is radioactive 2230 [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Ile4,Tyr-NH29]AVP
d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP 2237 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Val4,Tyr-NH29]AVP
[125I]d(CH2)5[D-Ile2,Val4,Tyr-NH29]AVP Ligand is labelled Ligand is radioactive 2231 [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Ile2,Val4,Tyr-NH29]AVP
[125I]d(CH2)5[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP Ligand is labelled Ligand is radioactive 2232 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Ile4,Tyr-NH29]AVP
d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP 2216 β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Val4,Tyr-NH29]AVP
[125I]d(CH2)5[D-Tyr(Et)2,Val4,Tyr-NH29]AVP Ligand is labelled Ligand is radioactive 2233 [125I]β-mercapto-β,β,cyclopentamethylenepropionyl[D-Tyr(Et)2,Val4,Tyr-NH29]AVP
d(CH2)5[Tyr(Et)2,Val4,des-Gly9]AVP 2217 dGTyr(Et)VAVP, Mcp-tva-argipressin, SK&F 101926, SK&F 10196
d(CH2)5[Tyr(Me)2,Arg8]VP 3867
d(CH2)5[Tyr(Me)2]AVP 2223 CGP-25838, d(CH2)5Tyr(Me)AVP, d(CH2)5[O-methyl-Tyr2]AVP, Pmp[Tyr(Me)2]AVP, SKF-100273, SKF100273
[3H]d(CH2)5[Tyr(Me)2]AVP Ligand is labelled Ligand is radioactive 3813 [3H]-d(CH2)5[Tyr(Me)2,Arg8]AVP
[125I]d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT Ligand is labelled Ligand is radioactive 3778 [125I]-d(CH2)5[Tyr(Me)2,Thr4,Orn8,Tyr-NH29]OVT
d(CH2)5[Tyr(Me)2,Thr4]OVT 2222 d(CH2)5[O-Me-Tyr2,Thr4,Orn8]vasotocin, d(CH2)5[O-Me-Tyr2,Thr4]ornithine vasotocin, d(CH2)5[O-Me-Tyr2-The4-Orn8]vasotocin
d(CH2)5[Tyr(Me)2,Thr4,Phe(3I,4N3)-NH29]OVT 2219 d(CH2)5[Tyr(Me)2,Thr4,Orn8,Phe(3I,4N3)-NH29]vasotocin, I-ZOTA
d(CH2)5[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT Ligand is labelled Ligand is radioactive 2218 β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Phe(3125I,4N3)-NH29]OVT, [125I]ZOTA, d(CH2)5[Tyr(Me)2,Thr4,Orn8,Phe(3125I,4N3)-NH29]vasotocin
d(CH2)5[Tyr(Me)2,Thr4,Tyr(3125I)-NH29]OVT Ligand is labelled Ligand is radioactive 2220 [125I]D-(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]ornithine vasotocin, [125I]OTA
d(CH2)5[Tyr(Me)2,Thr4,Tyr-NH29]OVT 2221 β-mercapto-β,β,cyclopentamethylenepropionyl[Tyr(Me)2,Thr4,Tyr-NH29]OVT, d(CH2)5[O-Me-Tyr2-Thr4-Orn8-Tyr9-NH2]vasotocin, Pmp[Tyr(Me)2,Thr4,Tyr-NH29]ornithine vasotocin
[D-Cys(tBu)5]NPS 5810
[3H]d[D-Arg8]VP Ligand is labelled Ligand is radioactive 5403 [3H]-d[D-Arg8]VP, [3H][D-Arg8]vasopressin, [3H]DAVP
[3H]dDAVP Ligand is labelled Ligand is radioactive 2228 [3H]deamino arginine vasopressin, [3H]desmopressin
d[D-Pal2]AVP 2184 d[D-3-Pal2]AVP, Schwartz compound
d[D-Phe2]AVP 2185 [deamino-Cys1,D-Phe2]AVP
degarelix Approved drug 5585 FE200486, Firmagon®
delcasertib 7840 BMS-875944, CS-9803, KAI-9803
deltorphin II 1615 (Ala(2))deltorphin II, (Ala(2),glu(4))deltorphin, Delt II, Delt-II
[3H]deltorphin II Ligand is labelled Ligand is radioactive 3816 [3H]-deltorphin II
demotate 2 5636 N(4) (0-1),Asp0,Tyr3-octreotate
Dendroaspis natriuretic peptide 9070 DNP
α-dendrotoxin 2563 α-DTX
dendrotoxin-I 2544 dendrotoxin, dendrotoxin I, venom basic protease inhibitor 1
dendrotoxin-k 7738 DTX-K, Kunitz-type serine protease inhibitor homolog dendrotoxin K, venom basic protease inhibitor K
denileukin diftitox Approved drug Immunopharmacology Ligand 7044 DAB389 IL2, denileukin diftitox-cxdl, LY 335348, Lymphir®, Ontak®
Des-AA1,2,5,12,13-[D-Trp8]SRIF 2009
Des-AA5-[D-Trp8]SRIF 2012
Des-AA1,5-[Tyr2,D-Trp8,IAmp9]SRIF 2011 CH-288
(des 1-8) A-chain INSL3 analogue 3754
Des-Ala1,2,5-[D-Trp8,IAmp9]SRIF 2010
[des-Arg10]icatibant 663 [D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]-des-Arg9]bradykinin, [des-Arg10]HOE140
[des-Arg11]T-kinin 645 [Ile,Ser,des-Arg9]bradykinin
[des-Gly10,D-Ala6]GnRH N-ethylamide 1174
[125I][des-Gly10,D-Ala6]GnRH N-ethylamide Ligand is labelled Ligand is radioactive 1166
desGlyNH2-d(CH2)5[Tyr(Me)2,Thr4,Orn8]OT 3870
[3H]desGly-NH2[D-Ile2,Ile4]VP Ligand is labelled Ligand is radioactive 3817 [3H]-desGly-NH2[D-Ile2,Ile4]AVP
des-His1-[Glu9]glucagon-NH2 1150 des-His(1)-[Glu9]-glucagon-NH2
des-His1-[Leu4-Glu9]glucagon-NH2 1151 des-His(1)-[Leu4-Glu9]-glucagon-NH2
desirudin Approved drug 6458 CGP 39393, CGP-39393, CGP39393
deslorelin 9343
desmopressin Approved drug 2182 1-deamino,D-AVP, [deamino-Cys1,D-Arg8]vasopressin, dDAVP, Noctiva®
[des-Phe9,des-Arg10]kallidin 647 [Lys,des-Phe8,Arg9]bradykinin
[des-Pro8,des-Phe9,des-Arg10]kallidin 648 [des-Pro7,Phe8,Arg9]Lys-bradykinin
desulfated cholecystokinin-8 3725 CCK-8 (desulphated), des-CCK-8, desulfated sincalide
DFGYVAE 3023
difelikefalin Approved drug Immunopharmacology Ligand 9044 CR845, D-Phe-D-Phe-D-Leu-D-Lys-[γ-(4-N-piperidinyl)amino carboxylic acid], FE-202845, Kapruvia®, Korsuva®, SEQ ID NO: 2
DkTx 4178 Double-knot toxin
d[Leu4]AVP 2190 [deamino-Cys1,Leu4,Arg8]vasopressin
d[Leu4,Dap8]VP 2189 [deamino-Cys1,Leu4,Dap8]vasopressin
d[Leu4Lys8]VP 2191 [deamino-Cys1,Leu4,Lys8]vasopressin, d[Leu4,Lys8]VP, d[Leu4]LVP, d[Leu4]lysine vasopressin
D-Lys0-[des-Arg10]kallidin 636 D-[Lys,Lys,des-Arg9]bradykinin
[D-Lys1,des-Arg10]kallidin 640 D-[Lys,des-Arg9]bradykinin
[D-Lys3]-GHRP-6 11814 [D-Lys] GHRP-6
[D-Lys6]GnRH-II 5581
1DMe 1477 [D-Tyr1,(NMe)Phe3]neuropeptide FF, [D.Tyr1,(N.Me)Phe3]NPFF
[125I]1DMe Ligand is labelled Ligand is radioactive 1483
dNal-cyc(Cys-Tyr-dTrp-Orn-Val)-Nal-NH2 3871
D-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Nal-NH2 635 analogue #30 [PMID: 19463875]
D-Nal,Cys,Tyr,D-Trp,Orn,Val,Cys,Nal-NH2 6172
dNPA 1489
dolcanatide 10011
DOTA-BASS 5645 DOTA-BASS analog 2
[111In]DOTA-BOC-ATE Ligand is labelled Ligand is radioactive 2063 [111In-DOTA]-BOC-ATE, [InIII-DOTA]-BOC-ATE, [InIII-DOTA]-BOC-ATE
[111In]DOTA-dLVT Ligand is labelled Ligand is radioactive 3756 [111In]-DOTA-dLVT, [111In]-DOTA-Lys8-deamino-vasotocin, [111indium]DOTA-dLVT
DOTA/Eu relaxin-3 Ligand is labelled 11912
DOTA-JR11 10113
[111In,90Y]DOTA-LAN Ligand is labelled Ligand is radioactive 2056 DOTA-conjugated peptide, YIII-DOTA-LAN
[111In]DOTA-NOC Ligand is labelled Ligand is radioactive 2045 [111In-DOTA]-NOC, [InIII-DOTA]-NOC, [InIII-DOTA]-NOC
[111In,90Y]DOTA-NOC Ligand is labelled Ligand is radioactive 2057 90Y-DOTA-NOC, [90Y-DOTA]-1-Nal3-octreotide, YIII-DOTA-NOC
[111In]DOTA-NOC-ATE Ligand is labelled Ligand is radioactive 2064 [111In-DOTA]-NOC-ATE, [InIII-DOTA]-NOC-ATE, [InIII-DOTA]-NOC-ATE
[111In,90Y]DOTA-OC Ligand is labelled Ligand is radioactive 2058 [3Y]DOTA-OC, [3Y]DOTA-octreotide, YIII-DOTA-OC
[111In,90Y]DOTA-TOC Ligand is labelled Ligand is radioactive 2059 YIII-DOTA-TOC, YIII-DOTA-Tyr3-octreotide, YIII-DOTA-TOC
DPDPE 1608 2,5-pen-enkephalin, D-penicillamine (2,5)-enkephalin, DPLPE
[3H]DPDPE Ligand is labelled Ligand is radioactive 3819 [3H]-[d-Pen2,d-Pen5]-Enkephalin, [3H]-DPDPE
d[Pen1,Tyr(Me)2]AVP 2225 1-deaminopenicillamine-2-(O-methyl-tyr)-argipressin, dPTyr(Me)AVP
[D-Phe6,β-Ala11,Phe13,Nle14]bombesin-(6-14) 632 [D-Phe6,β-Ala11,Phe13,Nle14]bombesin(6-14)
[D-Phe12]bombesin 6181
[D-Phe6]bombesin(6-13)methyl ester 6180
[D-Phe6]bombesin(6-13)propylamide 6182
D-Phe-CRF-(12-41) 3865 D-Phe-corticotropin-releasing factor(12-41), D-Phe-CRF(12-41), D-Phe12,Nle21,38,αMeLeu37-CRF
[D-Phe6, Leu13, Cpa14,ψ13-14]bombesin-(6-14) 3840 [D-Phe6,Cpa14,ψ13-14]bombesin6-14, [D-Phe6,Leu13,Cpa14,ψ13-14]bombesin-(6-14), analogue #7 [PMID: 19463875]
[D-Phe6, Stat13, Leu14]Bn(6-14) 12494 RM-2, RM2
DPK-060 14113 GKH17-WWW
[D-Pro4,D-Trp7,9,10]substance P (4-11) 6185
drotrecogin alfa Approved drug 6788 drotrecogin alfa (activated), HSDB 7366, Xigris®
DSLET 1609 [D-Ser2, Leu5, Thr6]-enkephalin, Dislet, DSTLE
D1SP 13660
DSTBULET 3873
(D-Thr6, D-Trp8,9)galanin(1-15)ol 6133 (D-THR6,D-TRP8,9,L-ALANINOL15)-GALANIN (1-15)
[D-Tpi6, Leu13 ψ(CH2NH)-Leu14]bombesin-(6-14) 6183 (D-Tpi6, Leu13ψ(CH2-NH)-Leu14)bombesin (6-14), D-Tpi-Gln-Trp-Ala-Val-Gly-His-Leu-Y(CH2-NH)-Leu-NH2 trifluoroacetate salt, RC-3095
[D-Trp2]galanin-(1-29) 3866 [D-Trp2]galanin(1-29)
[D-Trp8]γ-MSH 1334 D-Trp8 γ-melanocyte stimulating hormone, D-Trp8 γ-MSH, D-Trp8-y-MSH
[D-Trp11]neurotensin 1584 D-Trp11-neurotensin
[D-Trp32]NPY 1544 [D-Trp32] neuropeptide Y, [D-Trp32]-NPY
[D-Trp12]PTH-(7-34) (bovine) 1820 [D-Trp12]-PTH 7-34 (bovine)
[D-Trp12,Tyr34]PTH-(7-34) (bovine) 1819 [D-Trp12,Tyr34]-PTH 7-34 (bovine)
[125I]α-DTX Ligand is labelled Ligand is radioactive 2564
[D-Tyr6,β-Ala11,N-Me-Ala13,Nle14]bombesin-(6-14) 11434
[125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin-(6-14) Ligand is labelled Ligand is radioactive 631 [125I]-[Tyr6,βAla11,Phe13,Nle14] bombasin-6-14, [125I][D-Tyr6,β-Ala11,Phe13,Nle14]bombesin(6-14)
[D-Tyr6,Apa-4Cl11,Phe13,Nle14]bombesin-(6-14) 3946 [D-Tyr6,Apa-4Cl11,Phe13,Nle14]bombesin6-14
[D-Tyr6,(R)-APA11,Phe13,Nle14]bombesin-(6-14) 633 [D-Phe6,(R)-APA11,Phe13,Nle14]bombesin(6-14)
[125I][D-Tyr6]bombesin-(6-13)-methyl ester Ligand is labelled Ligand is radioactive 628
[D-Tyr8]CYN 154806 2028 cyanamid 154806, CYN 154806, D-Tyr8-CYN 154806
[125I]DTyr-Gly-[(Nle28,31)CCK-26-33 Ligand is labelled Ligand is radioactive 6666
dulaglutide Approved drug 7638 GLP-1Fc, LY2189265, Trulicity®
duramycin 841
dusquetide 14001 IMX942, SGX942
d[Val4,DArg8]VP 3869
[D-Val5]NPS 5811
dVDAVP 2183 1-deamino-4-val-8-arg-vasopressin, [deamino-Cys1,Val4,D-Arg8]AVP, d[Val4]AVP
DW13.3 2527 ω-filistatoxin-Kh1a, ω-FLTX-Kh1a, DW13.3 toxin
DX600 11602 DX-600
[dY]1KP-10 4015
dynorphin-(1-11) 1618 dynorphin 1-11, dynorphin A (1-11)
dynorphin-(1-17)-NH2 1661 dynorphin 1-17-NH2
 
E Back to top
E2078 1648 E 2078, E-2078, N-Me-tyr(1)-N-Me-arg(7)-N-Et-leunh2(8)-dynorphin (1-8), N-methyl-Tyr1,N-methyl-Arg7,D-leu8-dynorphin-A(1-8)
E7 3915 (Trp63-Trp64)-C3a-(63-77), C3a receptor superagonist, EP141
EC 5-21 2044
ecallantide Approved drug Immunopharmacology Ligand 6955 DX-88, FOV2302, Kalbitor®
echistatin 6594
ecnoglutide 13970 XW-003, XW003
E. coli heat-stable enterotoxin (STa) 4854
edotreotide Approved drug 5638 DOTA-Tyr3-octreotide, DOTA0-Phe1-Tyr3-octreotide, Ga-DOTA-TOC, Ga-DOTATOC, SMT487, SomaKit TOC®
efanesoctocog alfa Approved drug 13086 ALTUVIIIO®, Altuvoct®, BIVV-001, BIVV001, Fc-VWF-XTEN
efineptakin alfa Immunopharmacology Ligand 11097 GX-I7, Hyleukin-7, Il-7 hybrid Fc, NT-I7, rhIL-7-hyFc, TJ-107
eflapegrastim Approved drug 12180 eflapegrastim-xnst, HM-10460A, HM10460A, rolontis, Rolvedon®, SPI-2012, SPI2012
EFWSLAAPQRF-NH2 1478 EFW-NPSF
efzofitimod Immunopharmacology Ligand 13199 ATYR-1923, ATYR1923, KRP-R120
EG3287 11290 VEGFA(138-165)
[125I]EGF (human) Ligand is labelled Ligand is radioactive 4848 [125I]-epidermal growth factor
EISAI-1 1566
EISAI-2 1567
EK-1 11500
EK-1-C4 11501 EK1C4
eledoisin 2086 ELD 950, ELD-950, eledone peptide
elosulfase alfa Approved drug 7392 BMN 110, rhGALNS, Vimizim®
eneboparatide 13815 AZP-3601, AZP3601, LA-PTH
enlicitide 13944
ensovibep 11470 MP-0420, MP0420
ErgTx-1 2612 CnErg1, CnErgTx1, ergtoxin, ergtoxin-like protein 1, ErgTx, ErgTx1, potassium channel toxin gamma-KTx 1.1
etanercept Approved drug Immunopharmacology Ligand 6789 Enbrel®, Rhu Tnfr:Fc, TNFR-Fc, TNR 001
etelcalcetide Approved drug 8375 AMG 416, AMG-416, KAI-4169, Parsabiv®, velcalcetide
[125I]ET-2 (human) Ligand is labelled Ligand is radioactive 992 [125I]endothelin-2
[125I]ET-1 (human, mouse, rat) Ligand is labelled Ligand is radioactive 991 [125I]endothelin-1
[18F]ET-1 (human, mouse, rat) Ligand is labelled Ligand is radioactive 994 [18F]endothelin-1
ETN029 14192 ETN-029, MC339
Eu-DTPA-hC3a Ligand is labelled 11286
Eu-DTPA-[Ser27, Nle70]hC5a Ligand is labelled 12516
europium-labelled INSL3 Ligand is labelled 3875
europium-labelled INSL5 Ligand is labelled 4375
europium-labelled mouse INSL5 Ligand is labelled 6522
europium-labelled R3(B1-22R) Ligand is labelled 8342 Eu R3(B1-22R)
europium-labelled relaxin Ligand is labelled 3874 europium-labelled H2 relaxin
europium-labelled relaxin-3-B/INSL5 A chimera Ligand is labelled 4374 Eu-R3/I5, europium-labelled H3-B/INSL5 A chimera
evorpacept 11592 ALX-148, ALX148
examorelin 1100 EP-23905, hexarelin, MF-6003
exendin-3 3730
exendin-4 Approved drug 1135 AC 2993, AC002993, AC2993A, Bydureon®, Byetta®
exendin-(9-39) 1138 exendin (9-39), exendin 3 [Heloderma horridum horridum (Mexican beaded lizard)] (9-39)-peptide 39-amide (from INN record), exendin(9-39), exendin-(9-39) amide, Exendin-3-(9-39) amide
[125I]exendin-(9-39) Ligand is labelled Ligand is radioactive 1137 [125I]exendin (9-39)
[125I]EYF Ligand is labelled Ligand is radioactive 1488 [125I]-EYF
[3H]EYF Ligand is labelled Ligand is radioactive 4021 [3H]-EYF
 
F Back to top
F180 2171 [2-hydroxy-3-mercaptopropionic acid-1, Phe-2, Hgn-4. Dab(Abu)-8]OT, F 180
fertirelin 9341
[F/G]N/OFQ-(1-13)-NH2 1690 [F/G]N/OFQ(1-13)NH2, [F/G]nociceptin(1-13)NH2, [F/G]nociceptin/orphanin FQ(1-13)NH2, [F/G]orphanin FQ(1-13)NH2
filgrastim Approved drug Immunopharmacology Ligand 6968 Filcad®, Imumax ®, R-METHUG-CSF
FK 224 2103 FK-224, FK224
FLPLAR 5761
FLTChaAR 5777
F2L-[125I]Tyr Ligand is labelled Ligand is radioactive 1045
Flu-CCL3 Ligand is labelled 760 Flu-LD78α, Flu-MIP-1α, fluorescent macrophage inflammatory protein-1α
4-fluorobenzoyl-FGLRW-NH2 4014
fMet-Ile-Phe-Leu 1021 fMet-Ile-Phe-Leu [S. aureus]
fMet-Ile-Val-Ile-Leu 5842 fMet-Ile-Val-Ile-Leu [L. monocytogenes]
fMet-Ile-Val-Thr-Leu-Phe 5841 fMet-Ile-Val-Thr-Leu-Phe [L. monocytogenes]
fMet-Leu-Phe 1022 fMLP, fMetLeuPhe, fMLF, formyl-Met-Leu-Phe
[3H]fMet-Leu-Phe Ligand is labelled Ligand is radioactive 1018 [3H]fMet-Leu-Phe, [3H]fMLP
fMet-Leu-Phe-Glu 5840 fMet-Leu-Phe-Glu [E. coli]
fMet-Leu-Phe-Ile-Ile 14145 fMLFII
fMet-Leu-Phe-Ile-Ile-Lys-FITC Ligand is labelled 5843
fMet-Met-Trp-Leu-Leu 5837
fMet-Met-Tyr-Ala-Leu-Phe 1023 fMet-Met-Tyr-Ala-Leu-Phe [Mitochondria]
FMRFamide 4195 Phe-Met-Arg-Phe-amide
FP-1039 11581 FGFR1:Fc, FP1039, GSK-3052230, GSK3052230, HGS1036
F peptide 6247
(3,5)-[19F]2-Phe-ψ-Ala Ligand is labelled Ligand is radioactive 11370 (3,5)-difluoro Phe-ψ-Ala
FPRL1-inhibitor protein 6264 FLIPr
FPYVAE peptide [PMID: 20494585] 3024
FSH deglycosylated α/β 1158
[125I]FSH (human) Ligand is labelled Ligand is radioactive 3780 [125I]-follicle-stimulating hormone, [125I]-FSH
FSH α subunit-deglycosylated form 5536
FSH β subunit-deglycosylated form 5537
furin inhibitor peptide 8668
2-furoyl-LIGRL[N-(Alexa Fluor 594)-O]-NH2 Ligand is labelled 4050 Alexa Fluor 594-2fLI
[3H]2-furoyl-LIGRL-NH2 Ligand is labelled Ligand is radioactive 6660
2-furoyl-LIGRL[N[3H]propionyl]-O-NH2 Ligand is labelled Ligand is radioactive 4049 [3H]propionyl-2fLI
2-furoyl-LIGRLO-amide 3851
Fz7-21 10324
 
G Back to top
G4120 6588 cyclic Arg-Gly-Asp-containing pentapeptide, cyclic RGD, G 4120, G-4120, L-cysteine, N-(mercaptoacetyl)-D-tyrosyl-L-arginylglycyl-L-alpha- aspartyl-cyclic(1-->5)-sulfide, 5-oxide
Ga-DOTA-NOC 5639
[Ga-DOTA,Tyr3,Thr8]octreotide 5632 Ga-DOTA-octreotate, Ga-DOTA-TATE, Ga-DOTATATE
Ga-KE88 5640
galanin  {Sp: Pig} 6129
galanin(1-10) 6140
galanin(1-11) 6084 AR-M1717
galanin-(1-11) 5356 galanin (1-11)
galanin(1-12) 6141
galanin(1-15) 6086
galanin(2-11) 5357 AR-M1896
galanin(1-13)amide 6085
galanin(D-Trp2) (pig) 6095
galanin(1-19) (human) 6088
galanin(1-20) (human) 6137
galanin(2-30) (human) 6090
galanin(3-30) (human) 6138
galanin-like peptide  {Sp: Pig} 6120
galanin(10-29) (pig) 6094
galanin(2-29) (pig) 6130
galanin(3-29) (pig) 6091
galanin(5-29) (pig) 5359 galanin (5-29) (pig)
galanin(7-29) (pig) 6083
galanin(10-29) (rat/mouse) 6093
galanin(1-19) (rat/mouse) 6139
galanin(2-29) (rat/mouse) 3876 galanin (2-29)
galanin(3-29) (rat/mouse) 6092
galanin(5-29) (rat/mouse) 6134
galanin(9-25) (rat/mouse) 6136
galanin(9-29) (rat/mouse) 6135
galanin(1-16) (rat/mouse/pig) 6087
Gal-B2 6105 NAX 5055
Gal-B5 6107
Gal-B2-C10 6112
Gal-B2-C12 6113
Gal-B2-C14 6114
Gal-B2-C18 6115
Gal-B2-C8 6111
Gal-B2-dPEG24 6106
Gal-B2-MPEG4 6116
Gal-(K)4 6110
galparan 6096
GALP(1-32) (human) 6121
GALP(3-32) (human) 6122
Gal-R2-dPEG24 6108
ganirelix Approved drug 3877 D 24598, D-24598, Orgalutran®, RS 26306, RS-26306
Ga-NODAGA-LM3 5643
[125I]gastrin Ligand is labelled Ligand is radioactive 3781 [125I]-gastrin
[3H]gastrin Ligand is labelled Ligand is radioactive 3821 [3H]-gastrin
gastrin-releasing peptide  {Sp: Pig} 3581
gastrin releasing peptide(14-27) (human) 6175 GRP(14-27)
GaTx1 4198 Toxin GaTx1
GaTx2 4199
[G(B24)S]R3/I5 11909
GC-373 11635 GC373, N-benzyloxycarbonyl-L-leucyl-3-(2-oxopyrrolidin-3-yl)-L-alaninal
[125I]GDNF (rat) Ligand is labelled Ligand is radioactive 4851 [125I]-GDNF (rat)
GE-137 Ligand is labelled 8585
gG-2p20 5839
[125I]GHRH (human) Ligand is labelled Ligand is radioactive 3783 [125I]-GHRH, [125I]-growth hormone releasing hormone, [125I]-Tyr10-hGHRH(1-44)NH2, [125I]GHRH(1-44)NH2
GHRH-(1-29)-NH2 (human) 1103 GHRH (1-29)NH2 (human), human growth hormone releasing hormone (1-29)NH2
GHRH-(1-29)-NH2 (rat) 1104 GHRH(1-29)NH2 (rat), rat growth hormone releasing hormone (1-29)NH2
GHRH-(1-29)-OH (human) 1105 GHRH(1-29)OH (human), human growth hormone releasing hormone (1-29)OH
GHRP-6 1093 GH-releasing hexapeptide 6, growth hormone releasing hexapeptide, growth hormone releasing peptide-6, Skf 110679
GIP-(10-30) 1128 gastric inhibitory polypeptide10-30, GIP10-30
GIP-(7-30) 1130 gastric inhibitory polypeptide7-30, GIP7-30
GIP-(6-30)-amide 1129 gastric inhibitory polypeptide6-30 amide, GIP6-30 amide
[125I]GIP (human) Ligand is labelled Ligand is radioactive 1131 [125I]-GIP, [125I]gastric inhibitory polypeptide
glepaglutide 10885 ZP-1848, ZP1848
[Gln8]GnRH 1169 chicken GnRH
GLP-1-(9-36) 6524
[125I]GLP-1-(7-36)-amide Ligand is labelled Ligand is radioactive 1134 [125I]GLP-1, [125I]GLP-1(7-36)amide, [125I]glucagon-like peptide 1 (7-36)
GLP-2 analogue 10 Immunopharmacology Ligand 9896
GLPDGG peptide [PMID: 20494585] 2980
[125I]GLP-1-(7-37) (human) Ligand is labelled Ligand is radioactive 3784 [125I]-GLP-1(7-37), [125I]-glucagon-like peptide-1(7-37), [125I]GLP-1(7-37)
[125I][Glp65Nle75,Tyr77]apelin-13 Ligand is labelled Ligand is radioactive 3761 [125I](Pyr1)[Nle75,Tyr77]-apelin-13, [125I]-[Glp65Nle75,Tyr77]apelin-13, [125I][Glu65,Nle75,Tyr77]apelin-13
GLP-2-(1-29) (rat) 1139 GLP-2 (1-29) (rat), rat glucagon-like peptide 2 (1-29)
glucagon-(1-21) 1146 glucagon 1-21
glucagon-(1-6) 1147 glucagon 1-6
[125I]glucagon (human, mouse, rat) Ligand is labelled Ligand is radioactive 3785 [125I]-glucagon
glucarpidase Approved drug 7450 Voraxaze®
glutathione PDB Ligand 6737 GSH
glycyl-sarcosine 9505 Gly-Sar, glycylsarcosine
GM-109 1466 GM 109, GM109
GMAP(1-41)  {Sp: Pig} 6131 galanin message associated peptide fragment 1-41 amide, porcine, preprogalanin 65-105 amide
GMAP(44-59)  {Sp: Pig} 6132 galanin message associated peptide fragment 44-59 amide, preprogalanin 108-123 amide
[125I]GnRH I (human, mouse, rat) Ligand is labelled Ligand is radioactive 3786 [125I]-GnRH I, [125I]-gonadotropin-releasing hormone I
[125I]GnRH II (human) Ligand is labelled Ligand is radioactive 3787 [125I]-GnRH II, [125I]-gonadotropin-releasing hormone II
GnRH III 3878 gonadoliberin III, gonadoliberin-3, Gonadotropin-releasing hormone III, lamprey GnRH III, Luliberin III
goserelin Approved drug 3879 decapeptide I, ICI 118630, Zoladex®
gosteganan 14105 HPRP-A1, PL-18
GR100679 3880 GR 100679, GR-100679
GR138676 2128 GR 138676, GR-138676
GR231118 1529 GR 231118, GR-231118, GW 1229, GW-1229, GW1229
GR64349 3881 GR-64349, Lys-Asp-Ser-Phe-Val-Gly-(R-γ-lactam)
GR94800 3882 GR 94800, GR-94800
[125I]GR231118 Ligand is labelled Ligand is radioactive 1531 [125I]1229U91, [125I]GW1229
[3H]GR100679 Ligand is labelled Ligand is radioactive 3822 [3H]-GR100679
ω-grammotoxin SIA 2539 ω-GrTx SIA, omega-grammotoxin SIA, omega-GsTx SIA, omega-GTX SIA
GRASP 12844
[125I]GRP (human) Ligand is labelled Ligand is radioactive 3788 [125I]-gastrin-releasing peptide, [125I]-GRP
GsMTx-4 4206 M-theraphotoxin-Gr1a, M-TRTX-Gr1a, MTx4, Toxin GsMTx-4
GxTx-1E 7760 κ-theraphotoxin-Pg1a, κ-TRTX-Pg1a, guangxitoxin-1E
GYPGKF-NH2 3883
GYPGQV-NH2 3739
 
H Back to top
H3 Ac-B10-27(13-17 HC) 11908
HAS-NMU 7925
[3H]haTRAP Ligand is labelled Ligand is radioactive 3823 [3H]-haTRAP, Ala-p-fluoroPhe-Ala-Arg-cyclohexylAla-homoArg-[3H]Tyr-amide
HaTx1 7762 κ-theraphotoxin-Gr1a, κ-TRTX-Gr1a, hanatoxin-1
H3B10-27(13/17αF) 14152
H-c[Cys-Phe-LAgl(NβMe,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH 2079
H-c[Cys-Phe-LAgl(NβMe,benzoyl)-Trp-Lys-Thr-Phe-Cys]-OH 2080
H-c[DCys-Phe-LAgl(NβMe,benzoyl)-DTrp-Lys-Thr-Phe-Cys]-OH 2081
H3-CoA-20 7035
HelaTx1 7737 HL15-1-1, potassium channel toxin kappa-KTx 5.1
α-helical CRF 923 α-helical corticotropin, α-helical CRF (9-41), alpha-helical CRF (9-41)
helodermin 2280 Exendin 2
HER-096 13049 HER096
heteropodatoxin-2 2581 κ-sparatoxin-Hv1b, κ-SPRTX-Hv1b, HpTX2, HpTx2, Toxin KJ6
δ-hexatoxin-Mg1a 7569 Delta-HXTX-Mg1a, neurotoxin magi-4
hGLP-2(1-33,M10Y) 11804
hGLP-2(3-33,M10Y) 11805
hINSL5: A8-21 (T15K) 12504 analogue 13 [PMID: 26824523]
hINSL5: A8-21 (T9R) 9324
Hip-His Leu 5197 Hippuryl-His-Leu
[His5,Arg19]PTH-(1-34) (human) 1793 [His5,Arg19]-PTH 1-34 (human)
[His5,D-Tyr6]GnRH 1170
[125I][His9]ghrelin (human) Ligand is labelled Ligand is radioactive 1094 [125I-His9]ghrelin, [125I] His9-ghrelin (human)
[His5]PTH-(1-34) (human) 1794 [His5]-PTH 1-34 (human)
histerelin 9344
histidyl-leucine 9485 His-leu, Histidylleucine, L-histidyl-L-leucine
histrelin Approved drug 3884 ORF 17070, RWJ 17070, Vantas®
[His4, Tyr5, Trp6, His7]TIP39 (human) 5572 [His4, Tyr5, Trp6, His7]-hTIP39, [His4, Tyr5, Trp6, His7]-TIP39 (human), HYWH-TIP39
HIV-1 matrix protein p17 8495
HIV-Tat 773 Tat1-86
hK2p01 derivative KLK2 inhibitor 8672
Hm1a 9553 δ-theraphotoxin-Hm1a
HmTx1 2580 κ-theraphotoxin-Hm1a, κ-TRTX-Hm1a, Heteroscodratoxin-1
hongotoxin-1 2545 HgTX1, potassium channel toxin α-KTx 2.5
Hp(2-20) 1046
HpARI Immunopharmacology Ligand 9685 H. polygyrus Alarmin Release Inhibitor
H. polygyrus TGF-β mimic Immunopharmacology Ligand 9713 Hp-TGM
[125I]Hpp-desArg10HOE140 Ligand is labelled Ligand is radioactive 3791 [125I]-Hpp-desArg9HOE140
[125I]HPP-HOE140 Ligand is labelled Ligand is radioactive 11436 [125I]-3-4-hydroxyphenyl-propionyl-d-Arg0-[Hyp3,Thi5,d-Tic7,Oic8]bradykinin
[125I]-HPP-icatibant Ligand is labelled Ligand is radioactive 11158 [(125)I]-HPP-Hoe 140, [125I]3-4 hydroxyphenyl-propionyl-D-Arg[Hyp3, Thi5, D-Tic7, Oic8]-BK, [125I]3-4 hydroxyphenyl-propionyl-D-Arg[Hyp3, Thi5, D-Tic7, Oic8]-bradykinin, [125I]3-4 hydroxyphenyl-propionyl-icatibant
HS014 1321 HS 014
HS024 1328 cyclic[AcCys3,Nle4,Arg5,D-Nal7,Cys-NH2(11)]alpha-MSH-(3-11), HS 024
H3 14s18 stapled B-chain 11910
HsTX1[R14A] Immunopharmacology Ligand 9582 KTx 6.3
5-HT-moduline 137 PEPTIDE1{L.S.A.L}$$$$
human GIP(1-30)NH2 8973
human GIP(3-30)NH2 8971
human GIP(3-42)NH2 8970
human GIP(5-30)NH2 8972
huwentoxin IV 7570 huwentoxin-4, HwTx-IV
[Hyp3,Tyr(Me)8]BK 3841 [Hyp3,Tyr(Me)8]bradykinin
 
I Back to top
iberiotoxin Immunopharmacology Ligand 4218 IbTX
i-Boc-Met-Leu-Phe 1028
icatibant Approved drug Immunopharmacology Ligand 667 D-Arg-[Hyp3,Thi5,D-Tic7,Oic8]BK, Firazyr®, HOE 140, HOE140
ICI 174,864 1636 ICI-174,864, ICI-174864
icotrokinra Immunopharmacology Ligand 14181 JNJ-2113, JNJ-77242113, JNJ77242113
γ-iE-DAP 9504 γ-D-glutamyl-meso-diaminopimelic acid, Gamma-D-Glu-mDAP, Gamma-d-glutamyl-meso-diaminopimelic acid, iE-DAP
IFN-β1a (recombinant human) Approved drug 8339 Avonex®, Rebif®
IFN-γ1b (human recombinant) Approved drug 8341 Actimmune®., IFNγ2a
IFN-α2b (recombinant human) Approved drug 8338 Intron A®, intronA
IFN-β1b (recombinant human) Approved drug Immunopharmacology Ligand 8340 Betaferon®, Betaseron®, Extavia®, IFNb1b
IgE heavy chain Immunopharmacology Ligand 9557
[Ile31,Gln34]PP (human) 1555 [Ile31,Gln34]-PP (human), human [Ile31,Gln34] pancreatic peptide
[Ile5,Glu19]PTHrP-(1-34) (human) 1796
[Ile5,Glu19,Val21]PTHrP-(1-34) (human) 1795 [Ile5,Glu19,Val21]-PTHrP 1-34 (human)
[Ile5]PTHrP-(1-36) 1825 [Ile5]-PTHrP 1-36
[Ile5]PTHrP-(1-34) (human) 1803 [Ile5]-PTHrP 1-34 (human)
[Ile5]PTHrP-(1-36) (human) 1804 [Ile5]-PTHrP 1-36 (human)
[Ile5,Trp23]PTHrP-(5-36) 1821 [Ile5,Trp23]-PTHrP 5-36
[Ile5,Trp23]PTHrP-(1-36) (human) 1798 [Ile5,Trp23]-PTHrP 1-36 (human)
[Ile5,Trp23]PTHrP-(2-36) (human) 1799 [Ile5,Trp23]-PTHrP 2-36 (human)
[Ile5,Trp23]PTHrP-(3-36) (human) 1800 [Ile5,Trp23]-PTHrP 3-36 (human)
[Ile5,Trp23]PTHrP-(4-36) (human) 1801 [Ile5,Trp23]-PTHrP 4-36 (human)
[Ile5,Trp23]PTHrP-(5-36) (human) 1824 [Ile5,Trp23]-PTHrP 5-36 (human)
[Ile5,Trp23,Tyr36]PTHrP-(1-36)-NH2 (human) 1797 [Ile5,Trp23,Tyr36]-PTHrP 1-36-NH2 (human)
[Ile5,Val21]PTHrP-(1-34) (human) 1802 [Ile5,Val21]-PTHrP 1-34 (human)
inbakicept 11593 15RalphaSu-Fc
In-NODAGATOC 5642 In-NODAGA-Tyr3-octreotide
INSL3 [A(5-26):B(7-27)] 11914
INSL5 amide (human) 8350
INSL5 amide (mouse) 8351
INSL5 analogue 13 11915
INSL5-A13NR 11919
INSL5-A13nRbW 14154 A13-nRbW
INSL3 B-chain analogue 3885
INSL3 B chain dimer analogue 8 4372
[125I]INSL3 (human) Ligand is labelled Ligand is radioactive 1996
[125I]INSL5 (human) Ligand is labelled Ligand is radioactive 2001 [125I]insulin-like peptide 5
insulin glargine Approved drug 7572 HOE-901, HOE901, Lantus®
[125I](3-iodo-Tyr13)-MCH Ligand is labelled Ligand is radioactive 1316
[3-iodo-Tyr6]U-II-(4-11) (human) 9436
ipafricept 10325 FZD8-Fc, OMP-54F28, OMP54F28
iPep-SARS2-E 13253 TAT-MY18-2ED
IPL344 13268 IPL-344
[3H]-IPP Ligand is labelled Ligand is radioactive 11368
IRL 2500 PDB Ligand 3887 IRL-2500, IRL2500
[125I]IRL1620 Ligand is labelled Ligand is radioactive 1007 [125I]-IRL1620, [125I]IRL 1620
iseganan 10822 IB-367, IB-367-03
isopropylureido-FLFLF 1041
Isox-Cha-Chg-Ala-Arg-Dpr(4FB)-NH2 12492
Isox-Cha-Chg-ARK(Sulfo-Cy5)-NH2 Ligand is labelled 12493
isunakinra Immunopharmacology Ligand 9704 EBI-005
iturelix 3854 antide, D 21074, ORF 23541
[125I-Tyr]Ac2-26 Ligand is labelled Ligand is radioactive 6198 [125I]ANXA1-derived peptide
 
J Back to top
J18 (galanin analogue) 6075
J20 (galanin analogue) 6076
JI-38 6523 [Dat1,Gln8,Orn12,21,Abu15,Nle27Asp28,Agm29]hGH-RH-(1-29)
jingzhaotoxin-III 2574 β-theraphotoxin-Cj1a, β-TRTX-Cj1a, Jingzhaotoxin-3, JZTX-III
jingzhaotoxin-XI 2575 κ-theraphotoxin-Cj1a, κ-TRTX-Cj1a, Jingzhaotoxin-11, JZTX-11, JZTX-XI
JMR-132 9114
JMV1116 670 JMV 1116, JMV-1116
JMV1431 656 JMV 1431, JMV-1431
JMV180 3888 Boc-Tyr(SO3H)Ahx-Gly-Trp-Ahx-Asp2phenylethyl ester, JMV 180, JMV-180
JMV2004 1568 JMV 2004, JMV-2004
JMV310 898 JMV 310, JMV-310
JMV431 1569 JMV 431, JMV-431
JMV449 1570 JMV 449, JMV-449
JMV457 1571 tert-butoxy-carbonyl-Arg-Arg-Pro-D-Tyr-Ile-Leu-OH, JMV 457
JMV458 1572 JMV 458, JMV-458
JMV594 624 [D-Phe6,Statine13]Bombesin(6-14), JMV 594
JMV641 3889 JMV 641, JMV-641
JPE1375 5763 JPE 1375
JV-1-10 1106 [PhAc-Tyr1,D-Arg2,Phe(4-Cl)6,Arg9,Abu15,Nle27, D-Arg29]hGH-RH(1-29)NH2
JV-1-36 1107 [PhAc-Tyr1,D-Arg2,Phe(4-Cl)6,Arg9,Abu15,Nle27,D-Arg28,Har29]hGH-RH(1-29)NH2, JV 1-36
JV-1-37 1108
JV-1-38 1109 JV 1-38
JV-1-39 1110
JV-1-40 1111
JV-1-41 1112
JV-1-42 1113 JV 1-42
JV-1-43 1114
JV-1-62 1115
JV-1-63 1116 JV 1-63
 
K Back to top
K31440 3890 Ac-(D-Tyr11,His12,Nle17)sauvagine(11-40), K 31440, K-31440
K41498 3891 [D-Phe11,His12,Nle17]sauvagine(11-40), K 41498, K-41498
kaliotoxin 2546 BmKTX, KTX, potassium channel toxin α-KTx 3.6
kassinin 2088
KBP-066 10660 DACRA, KBP 066, KBP066
KBP-088 10683 DACRA, KBP 088, KBP088, KeyBiosciencePeptide 088
[125I]KC-Tyr Ligand is labelled Ligand is radioactive 832
KE 108 2013 KE-108, KE108
KH28 5306 KH 28, KH-28
kisspeptin-15 1286 KP-15
kisspeptin-28 1287 KP-28
kisspeptin-9 1289 KP-9
[125I]kisspeptin-10 (human) Ligand is labelled Ligand is radioactive 1281 [125I]-KP10, [125I]KP-10
[125I]kisspeptin-13 (human) Ligand is labelled Ligand is radioactive 3792 [125I]-kisspeptin13, [125I]-KP13, [125I]KP13
[125I]kisspeptin-14 (human) Ligand is labelled Ligand is radioactive 4013 [125I]KP14
[125I]kisspeptin-54 (human) Ligand is labelled Ligand is radioactive 1282 [125I]KP-54, [125I]metastin
α-KTx 13.2 2550 OsK2
γ-KTx1.7 7689 CeErg4, potassium channel toxin gamma-KTx 1.7
kurtoxin 2521 Ktx
 
L Back to top
L-156,602 577 L 156602, PD 124966
L-362,823 2072 L 362823, L-362823
L-362,855 2014 L 362855, L-362855
L-363,301 2047 L 363301, L 363568, MK 301, MSD-L 363301
L-363,377 2048 L 363377, L-363377
L-363,409 2049 L 363409, MK 363-409
L-365,209 2241 L 365209, L-365209
L-366,682 2243 cyclo(Pro-Trp-Ile-Pip-Pip-His), L 366682
L-366,875 2244 L 366875, L-366875
L-366,948 2245 L 366948, L-366948
labradimil 672 [Hyp3,Thi5,4-Me-Tyr8ψ(CH2-NH)Arg9]bradykinin, cereport, lobradimil, RMP-7
lactomedin 1 10228
lanreotide Approved drug 2031 BIM 23014, DC 13-116, lanreotide acetate, Somatuline®
larazotide 13724 AT-1001, AT-2347, AT1001, AT2347
Large proline-rich protein BAG6 Immunopharmacology Ligand 11143 BAG6
lariocidin 14119
lasso D 5899
α-latrotoxin 5897 alpha-LTX, alpha-latrotoxin, alpha-latrotoxin-Lt1a, alpha-LTX-Lt1a
[L-Bpa5,Ile13]motilin (human) 1451
LCB1 11236
LCB3 11237
LDV-FITC Ligand is labelled 6759
Lei-Dab7 2315
leiurotoxin I 2316 Leiurotoxin-1 (LeTx1), potassium channel toxin α-KTx 5.1, scyllatoxin (ScyTx)
lepirudin Approved drug 6469 1-L-leucine-2-L-threonine-63-desulfohirudin, Refludan®
[Leu14]bombesin 11259
[Leu14, ψ 13-14)]bombesin 629
[Leu8,des-Arg9]bradykinin 641
[Leu9,des-Arg10]kallidin 642 [Lys,Leu8,des-Arg9]bradykinin, Lys-[Leu8][des-Arg9]BK, Lys-[Leu8][des-Arg9]bradykinin
[Leu13]motilin (human) 1453
[3H]Leu-N/OFQ Ligand is labelled Ligand is radioactive 3824 [3H]-Leu-N/OFQ, [3H]-Leu-nociceptin.orphanin FQ
[Leu8]-phyllolitorin 6168
leuprolide Approved drug 1175 ABBOTT-43818, Camcevi®, Fensolvi® (leuprolide acetate injectable suspension), Lupron®, TAP-144
[Leu31,Pro34]NPY 1545 [Leu31,Pro34] neuropeptide Y, [Leu31,Pro34]-NPY
[125I][Leu31,Pro34]NPY Ligand is labelled Ligand is radioactive 3762 [125I]-[Leu31,Pro34]neuropeptide Y, [125I]-[Leu31,Pro34]NPY
[Leu31,Pro34]NPY (pig) 1524 porcine [Leu31,Pro24] neuropeptide Y, porcine [Leu31,Pro34] neuropeptide Y
[Leu31,Pro34]PYY (human) 1527 human [Leu31,Pro34] peptide tyrosine tyrosine, human [Leu31,Pro34] peptide YY
[Leu31,Pro34]PYY (pig) 1526 [Leu31,Pro34] peptide tyrosine tyrosine, [Leu31,Pro34] peptide YY
LGR7-truncate 3893
[125I]LH Ligand is labelled Ligand is radioactive 3793 [125I]-LH, [125I]-luteinising hormone, [125I]-luteinizing hormone
LIH383 11084
linaclotide Approved drug 5017 Constella®, Linzess®, MM-416775
liraglutide Approved drug 1133 NN-2211 , NN2211, NNC 90-1170, NNC-90-1170, Victoza®
litorin 617 litorine
livoletide 10884 AZP-531, AZP531, Cyclo(des-acyl ghrelin(6-13)), Des-acyl ghrelin
lixisenatide Approved drug 7387 Adlyxin®, AVE-0010, Lyxumia®
[3H]-LKP Ligand is labelled Ligand is radioactive 11369
L-Phe-Phe-Phe 12435
Lqh Tx 15-1 14044
L-Trp-Trp-Trp 12424
[125I]LTT-SRIF-28 Ligand is labelled Ligand is radioactive 2023 3-[125I](Leu8, D-Trp22, Tyr25)somatostatin-28, 3-[125I]LTT-SRIF-28, [125I](Leu8, D-Trp22, Tyr25)-somatostatin-28
LTX(N4C) 5898 latrotoxin(N4C)
[L-Tyr8]CYN 154806 2029 cyanamid 154806
LUNA18 12931 compound 45 [PMID: 37463267]
luspatercept Approved drug 10538 ACE-536, ACE536, luspatercept-aamt, Reblozyl®
LV-2172 9442
LV-2186 10252 compound 5b
LV-2211 12420 [Tic22]26RFa(20-26), analog 28 [PMID: 34299587]
LVP  {Sp: Pig} 2172 [Lys8]-vasopressin, [Lys8]AVP, lysine vasopressin, syntopressin
LY3463251 12843
LY3540378 12502
[Lys15,Arg16,Leu27]VIP-(1-7)/GRF-(8-27)-NH2 3842 [K15, Arg16, Leu27]VIP(1-7)/GRF(8-27)
Lys-CoA 7036 Ac-Lys(CoA)-NH2
[3H]Lys-[des-Arg9]BK Ligand is labelled Ligand is radioactive 3825 [3H]-Lys-[des-Arg9]-bradykinin, [3H]-Lys-[des-Arg9]BK
Lys-kallidin 637 [Lys,Lys]bradykinin
[3H]Lys-[Leu8][des-Arg9]BK Ligand is labelled Ligand is radioactive 3826 [3H]-Lys-[Leu8][des-Arg9]-bradykinin, [3H]-Lys-[Leu8][des-Arg9]BK
[19Lys,26Leu]-galparan 6097
[Lys5,Me-Leu9,Nle10]NKA-(4-10) 3843 [Lys5,Me-Leu9,Mle10]neurokinin A(4-10)
Lys[Z(NO2)]-Val 9486
 
M Back to top
M1145 6101
M1151 6102 GWTLNSAGYLLGPK(ε-NH-C(O)X)-amide
M1152 6103 WTLNSAGYLLGPK(ε-NH-C(O)X)-amide
M1153 6104 RGRGNWTLNSAGYLLGPK(ε-NH-C(O)X)-amide
M1160 6074
M15 3896 galanin(1-13)substance P(5-11)amide, galantide
M242 6099 M 242, M-242
M32 3897 galanin(1-13)neuropeptide Y-amide(25-36)amide
M35 3898 galanin(1-13)bradykinin(2-9)amide
M372049 5020 M 372049, M-372049
M40 3899 galanin(1-13)Pro-Pro-Ala-Leu-Ala-Leu-Ala-Leu-Ala-amide
M617 6100
M65 3305 des-(Gln25-Gln41)-maxadilan, maxadilan Δ25-41
M871 3900 galanin(2-13)Glu-His-(Pro)3(Ala-Leu)2Ala-amide
maltotriose-[125I][Tyr3,Thr8]octreotide Ligand is labelled Ligand is radioactive 5631 [125I]-Mtr-TOCA, maltotriose-[125I]-Tyr3-octreotate
mambalgin-1 10308
mamba toxin CM-3 13153 Adrenergic toxin rho-elapitoxin-Dp1b, rho-EPTX-Dp1b
margatoxin 2547 MgTx, potassium channel toxin α-KTx 2.2
martentoxin 14032 MarTX
mast cell degranulating peptide 2548 MCD peptide, MCDP, Peptide 401
maurotoxin 2332 MTX, potassium channel toxin α-KTx 6.2
maxadilan 2264
Max.d.4 2265 des-(Leu24-Leu42)-maxadilan, maxadilan Δ24-42
mazdutide 13924 compound 1 [US9938335B2], IBI-362, IBI362, LY-3305677, LY3305677
MBP10 1339 MBP 10, MBP-10
MBP7 7038
MCH6-17 1293 melanin-concentrating hormone (6-17)
[125I]MCH (human, mouse, rat) Ligand is labelled Ligand is radioactive 1296 [125I]-melanin-concentrating hormone
[3H]MCH (human, mouse, rat) Ligand is labelled Ligand is radioactive 3827 [3H]-MCH, [3H]-melanin-concentraing hormone
MCH (salmon) 1301 salmon melanin-concentrating hormone
κM-conotoxin RIIIK 11476 κM-RIIIK, kappaM-RIIIK
MC148R 778 MC 148, MC 148 CC chemokine
MD5 13458 compound B [PMID: 39028865]
melittin 14002
MEN 10376 2116 [Tyr5,D-Trp6,8,9,Lys10]-alpha-NEUROKININ A, Fragment 4-10, MEN-10,376, MEN-10376, neurokinin A(4-10), Tyr(5)-Trp(6,8,9)-Lys(10)-
MEN10627 3901 cyc(2β-5β)(Met-Asp-Trp-Phe-Dap-Leu), MEN-10627
[125I][MePhe7]NKB Ligand is labelled Ligand is radioactive 3763 [125I]-[MePhe7]neurokinin A, [125I]-[MePhe7]NKB
Met-Ckβ7 788 Ckβ7, Met-chemokine β 7
[Met5]dynorphin-(1-17) 1659
Met-Lys-bradykinin 638 Met-kallidin
Met-Met-Trp-Leu-Leu 5836
metreleptin Approved drug 7333 Myalept®, r-metHuLeptin, R-methuleptin
MG-101 PDB Ligand 13381 MG101, N-acetyl-L-leucyl-L-leucyl-L-norleucinal
MG-115 11639 Cbz-Leu-Leu-norvalinal, N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-norvalinal, Z-LL-Nva-CHO
MG-132 PDB Ligand 8616 compound 5b [PMID: 16686537], MG132, N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal, Z-Leu-leu-leu-al, Z-LLL-CHO
mGIPAnt-1 11998
MHC binding peptide 6250
mideplanin 10830 CTA A1, MDL 62873, MDL-62873, MDL62873
minimised INSL5 analogue 7 8334
minimised INSL5 analogue 7 A chain 8335
minimised relaxin-3 analogue 2 8336
minimised relaxin-3 analogue 3 8326
minimised relaxin-3 analogue A chain 8327 minimised relaxin-3 analogue 2 A chain, minimised relaxin-3 analogue 3 A chain
minimised relaxin-3 analogue 3 B chain 8328
mini-TyrRS 823 NH2-terminal catalytic domain of human tyrosyl-tRNA synthetase
[125I]mini-TyrRS Ligand is labelled Ligand is radioactive 818 125I-NH2-terminal catalytic domain of human tyrosyl-tRNA synthetase
MIT1 1865 mamba intestinal toxin-1
mitochondrial peptde fMMYALF 14142
mitochondrial peptide fMFADRW 14144
MK-7110 Immunopharmacology Ligand 11395 CD24-Fc, CD24Fc
[125I]MK-678 Ligand is labelled Ligand is radioactive 2061
MLCK inhibitor peptide 18 9351 Myosin Light Chain Kinase Inhibitor Peptide 18
MM07 8523 cyclo[1-6]CRPRLCHKGPMPF
MM54 6186 cyclo(1-6)CRPRLC-KH-cyclo(9-14)CRPRLC
MMK-1 Immunopharmacology Ligand 6240 MMK 1
motilin  {Sp: Dog} 1457
motilin  {Sp: Rabbit} 1459
motilin-(1-11) (human) 1460 motilin1-11 (human)
motilin-(1-12) (human) 1461 motilin1-12 (human)
motilin-(1-13) (human) 1462 motilin1-13 (human)
motilin-(1-19) (human) 1463 motilin1-19 (human)
motilin-(2-22) (human) 1464 motilin2-22 (human)
[125I]motilin (human) Ligand is labelled Ligand is radioactive 3794 [125I]-motilin
motixafortide Approved drug Immunopharmacology Ligand 10679 4F-Benzoyl-TN14003, Aphexda®, BKT140, BL-8040, TF14016
[Mpa1,D-Tyr(Et)2,D-Tic7,Aib9]OT 2255 [deamino β-mercaptopropionic acid,-D-Tyr2,D-Tic7,Aib9]OT, [Mpa1,O-ethyl-D-Tyr2,D-Tic7,Aib9]OT
[Mpa1,D-Tyr(Et)2,D-Tic7,D-Tic9]OT 2254 [deamino β-mercaptopropionic acid,D-Tyr(Et)2,D-Tic7,D-Tic9]OT, [Mpa1,O-ethyl-D-Tyr2,D-Tic7,D-Tic9]OT
[Mpa1,D-Tyr(Et)2,D-Tic7]OT 2256 [deamino β-mercaptopropionic acid-D-Tyr(Et)2,D-Tic7]OT
MS05 1322
MT-II 1323 melanotan II, MTII
multi-Leu (ML)-peptide 8648 ML-peptide
murepavadin 10832 POL7080, RG-7929, RG7929, RO-7033877, RO7033877
muscarinic toxin 1 311 MT1, MTx1
muscarinic toxin 2 312 MT2, MTx2
muscarinic toxin 3 313 mamba toxin-3, MT3
muscarinic toxin 7 314 m1-toxin 1, MT7, recombinant mamba venom toxin, rMT7
muscarinic toxin β 13152 Adrenergic toxin rho-elapitoxin-Dp1a, MTβ, rho-EPTX-Dp1a
mutant ANP 10211 mANP, mutant atrial natriuretic peptide
myr-PKI 10619 Protein kinase inhibitor-(14-22)-amide, myristoylated
MZ-4-169 1117 [Nac0,D-Arg2,Phe(4-Cl)6,Abu15,Nle27]hGHRH-(1-29) NH2
MZ-4-181 1118 [Nac0-His1,D-Arg2,Phe(4-Cl)6,Abu15,Nle27]-hGH RH-(1-29)NH2
MZ-4-243 1119 [Nac0,D-Arg2,Phe(4-CI)6,Abu15,Nle27]hGHRH-(1-28)Agm
MZ-4-71 1120 MZ 4-71
MZ-5-156 1121 MZ 5-156
MZ-5-192 1122
MZ-5-78 1123
MZ-6-55 1124 [PhAc-Tyr1,D-Arg2,Phe(4-Cl)6,Abu15,Nle27,D-Arg28,Har29]hGH-RH(1-29)NH2, MZ 6-55
 
N Back to top
N-0385 11956 example 2 [WO2018112648A1], Ms-QFR-Kbt, N0385
N36 6246
NAB739 13588
N-Aβcore hexapeptide 13244 N-Aβ(10-15), N-Aβ10-15, N-Aβcore
N-α-Ac-PYY-(22-36) (rat) 1532 N-α-Ac-PYY22-36 (rat)
N-α-Ac-PYY-(25-36) (rat) 1533 N-α-Ac-PYY25-36 (rat)
nafarelin Approved drug 3902 Synarel®
Nanoluciferase-labelled relaxin Ligand is labelled 11464
NanoLuc-INSL3 Ligand is labelled 11913
NanoLuc R3/I5 chimera Ligand is labelled 11465
[125I]N-biotin-[Ahx0, Bpa3]U-II (human) Ligand is labelled Ligand is radioactive 9440
NC 8-12 2052
NC 4-28B 2017
5nd 8723
[125I]NDP-MSH Ligand is labelled Ligand is radioactive 1326 [125I]-NDP-MSH, [125I][Nle4,dPhe7]α-MSH
nepadutant 2123 LS-55819, MEN 11420, MEN-11420, MEN11420
nerinetide 12332 NA-1, Tat-NR2B9c
neuromedin B (1-30) (human) 6163 NMB30
neuromedin C 6178 NMC
neuromedin U-8  {Sp: Dog} 1472 NmU-8, canine neuromedin U-8
neuromedin U-25  {Sp: Pig} 1471 NmU-25, porcine neuromedin U-25
neuromedin U-8  {Sp: Pig} 1473 NmU-8, NMU-8, porcine neuromedin U-8
[125I]neuromedin U-25 (human) Ligand is labelled Ligand is radioactive 1474 [125I]NmU-25 (human), [125I]neuromedin U, [125I]NMU-25
[125I]neuromedin U-8 (pig) Ligand is labelled Ligand is radioactive 1476 [125I]NmU-8 (pig), porcine [125I]neuromedin U-8
[125I]neuromedin U-23 (rat) Ligand is labelled Ligand is radioactive 1475 [125I]NmU-23 (rat), rat [125I]neuromedin U-23
neuropeptide-γ 2092
neuropeptide head activator 2496 HA
neurotensin-(8-13) 7363
[125I]neurotensin (human, mouse, rat) Ligand is labelled Ligand is radioactive 1574 [125I]NT
[3H]neurotensin (human, mouse, rat) Ligand is labelled Ligand is radioactive 3830 [3H]-neurotensin
NG29 10254 SarLys[DPhe8]desArg9-bradykinin
NG291 10255 [Hyp3,Thi5,NChg7,Thi8]-bradykinin
[125I]NGF (human) Ligand is labelled Ligand is radioactive 4849 [125I]-nerve growth factor
[125I]NKA (human, mouse, rat) Ligand is labelled Ligand is radioactive 3795 [125I]-neurokinin A, [125I]-NKA
[125I][Nle75,Tyr77]apelin-36 (human) Ligand is labelled Ligand is radioactive 603
[Nle8,18,Tyr34]PTH-(1-34)-NH2 (bovine) 1805
[Nle8,18,Tyr34]PTH-(3-34)-NH2 (bovine) 1806
[125I][Nle8,21,Tyr34]PTH-(1-34)-NH2 (rat) Ligand is labelled Ligand is radioactive 1791
[nLeu13,Glu14]motilin (human) 1455
NM4-C16 9009
[N-Me,des-Sar]Gal-B2 6109
N-methyl-Phe-Lys-Pro-D-Cha-Cha-D-Arg-CO2H 572
N-methyl-Phe-Lys-Pro-D-Cha-Trp-D-Arg-CO2H 576
NMU (104-114) 10569
NN1213 13441 NN-1213, peptide 21 [PMID: 38960379]
NNC1702 9760 des-His1-[Glu9, Lys24(4 X γGlu), Leu27]glucagon
NOC-ATE 2053
N-octanoyl-L-homoserine lactone PDB Ligand 12447 C8-HSL, Octanoyl-L-homoserine lactone
NODAGA-[Tyr3]-octreotide 5627 NODAGA-Tyr3-octreotide, NODAGATOC
[67Ga]NODAGA-[Tyr3]octreotide Ligand is labelled Ligand is radioactive 5628 [67Ga]-NODAGA-Tyr3-octreotide, Ga-NODAGATOC
[3H]N/OFQ Ligand is labelled Ligand is radioactive 1688 [3H]nociceptin, [3H]nociceptin/orphanin FQ, [3H]orphanin FQ
N/OFQ-(1-13)-NH2 1682 nociceptin(1-13)NH2, nociceptin/orphanin FQ(1-13)NH2, orphanin FQ(1-13)NH2
N/OFQ-NH2 1683 nociceptin-NH2, nociceptin/orphanin FQ--NH2, orphanin FQ-NH2
nogapendekin alfa 11594 IL15 D72
NOSO-502 13157
novokinin 6893
noxiustoxin 2552 NTx, potassium channel toxin α-KTx 2.1, Toxin II.11
NPC 17731 657 D-Arg[Hyp3,trans-4-propoxy-D-proline(transpropyl)7,Oic8]bradykinin, NPC-17731, NPC17731
NPC 18565 658 [D-Arg(Hyp3,D-Hyp7(transpropyl),Oic8)des-Arg9]bradykinin, des-Arg9 fragment of NPC 17731, NPC-18565, NPC18565
NPC-349 675 [D-Arg0,Hyp2,3,Thi5,8,D-Phe7]bradykinin, NPC 349
NPC-567 676 [D-Arg0,Hyp3,D-Phe7]bradykinin, BIM 31006, NPC 567
[3H]NPC17731 Ligand is labelled Ligand is radioactive 3831 [3H]-NPC17731
[125I]NPFF Ligand is labelled Ligand is radioactive 3797 [125I]-neuropeptide FF, [125I]-NPFF
[Nphe1]N/OFQ-(1-13)-NH2 1695 [Nphe1]nociceptin(1-13)NH2, [Nphe1]nociceptin/orphanin FQ(1-13)NH2, [Nphe1]orphanin FQ(1-13)NH2
3-N3-Phpa-LVA 2193
[125I]3-N3-Phpa-LVA Ligand is labelled Ligand is radioactive 2206
[3H]NPVF Ligand is labelled Ligand is radioactive 4019 [3H]-NPVF, [3H]neuropeptide VF
[125I]NPW-23 (human) Ligand is labelled Ligand is radioactive 1497 [125I]neuropeptide W, [125I]neuropeptide W-23, [125I]NPW
NPY  {Sp: Pig} 1505 porcine neuropeptide Y
NPY-(13-36) 3903 neuropeptide Y (13-36)
NPY-(2-36) 1549 neuropeptide Y (2-36)
NPY-(13-36) (human) 1535 human neuropeptide Y (13-36)
[125I]NPY (human, mouse, rat) Ligand is labelled Ligand is radioactive 1518 [125I]neuropeptide Y
[3H]NPY (human, mouse, rat) Ligand is labelled Ligand is radioactive 1521 [3H]neuropeptide Y
NPY-(18-36) (human, pig) 1557 human neuropeptide Y (18-36), porcine neuropeptide Y (18-36)
NPY-(13-36) (pig) 1507 porcine neuropeptide Y (13-36)
NPY-(16-36) (pig) 1536 porcine neuropeptide Y (16-36)
NPY-(20-36) (pig) 1538 porcine neuropeptide Y (20-36)
NPY-(22-36) (pig) 1539 porcine neuropeptide Y (22-36)
NPY-(2-36) (pig) 1508 porcine neuropeptide Y (2-36)
NPY-(26-36) (pig) 1540 porcine neuropeptide Y (26-36)
NPY-(3-36) (pig) 1510 porcine neuropeptide Y (3-36)
Nrf2 peptide [PMID: 23647822] 8772
N-stearyl-[Nle17] neurotensin-(6-11)/VIP-(7-28) 2266 (SN)VIPhybrid, N-stearyl-[Nle17] neurotensin(6-11)/VIP(7-28)
N-stearyl-[Nle17]VIP 2271 N-stearyl-[Nle17]vasoactive intestinal peptide
NX210 13257 NX-210, NX-210c, NX210c, SCO-spondin derived peptide NX210
 
O Back to top
obtustatin 6581
ocriplasmin Approved drug 7446 Jetrea®, microplasmin
Octpep-1 12265
octreotide Approved drug 2055 DRG-0115, Mycapssa®, Sandostatin®, SMS 201,995
OH-LVA 2195
[125I]OH-LVA Ligand is labelled Ligand is radioactive 2207
OHM-11526 1467 [Phe3,Leu13]motilin (porcine)
olamkicept Immunopharmacology Ligand 9729 FE 999301, FE-301, FE-999301, TJ301
omiganan 14110 CLS001, MBI 226
OMN6 14120
ontorpacept 12036 TTI-621, TTI621
OP-145 13987 P60.4Ac
opiorphin 11538 Gln-Arg-Phe-Ser-Arg, L-Glutaminyl-L-arginyl-L-phenylalanyl-L-seryl-L-arginine, QRFSR peptide
oprelvekin Approved drug Immunopharmacology Ligand 6971 Neumega®
[125I]orexin A (human, mouse, rat) Ligand is labelled Ligand is radioactive 3798 [125I]-orexin A
[Orn5]URP 9438
oryzatensin 10227
OSK1-K16-D20 2556 [K16,D20]-OSK1
OSTN (115-133) 10570
OSTN (81-102) 10573
[3H]OT (human, mouse, rat) Ligand is labelled Ligand is radioactive 2176 [3H]oxytocin
 
P Back to top
P05 2325 AmP05, leiurotoxin I-like toxin P05, Potassium channel toxin α-KTx 5.2
P11 6595
PACAP-(6-38) 2267 pituitary adenylate cyclase activating polypeptide (6-38)
[125I]PACAP-27 Ligand is labelled Ligand is radioactive 2261 [125I]-PACAP-27, [125I]pituitary adenylate cyclase activating polypeptide-27
palifermin Approved drug 6954 Kepivance®, keratinocyte growth factor
palopegteriparatide Approved drug 13484 mPEG-PTH (1-34), TransCon PTH, Yorvipath®
Pam2CSK4 Immunopharmacology Ligand 8560
Pam3CSK4 Immunopharmacology Ligand 8558
[p-aminoPhe6]ang II 595 [p-aminoPhe6] angiotensin II
PAMP-12 (human) 4056 Human PAMP(9-20), proadrenomedullin N-terminal 20 Peptide (Human, 9-20)
pancreatic polypeptide  {Sp: Bovine} 1511 PP, bovine pancreatic polypeptide
pancreatic polypeptide  {Sp: European common frog} 1480 PP, frog pancreatic polypeptide
pandinotoxin-K α 2553 potassium channel toxin α-KTx 7.1, potassium channel-blocking toxin 2, toxin PiTX-K-α
pasireotide Approved drug 2018 pasireotide diaspartate, Signifor®, SOM 230, SOM 320, SOM-230
PBC-264 3948 pBC 264, propionyl-BC264
[3H]PBC-264 Ligand is labelled Ligand is radioactive 899 [3H]-Propionyl-BC-264, [3H]-Propionyl-BC264, [3H]propionyl-BC-264
PBP10 1043 PBP 10
pCXCL8-1aa Immunopharmacology Ligand 9938
[125I]PD151242 Ligand is labelled Ligand is radioactive 1001 [125I](N-[{hexahydro-1-azepinyl}carbonyl])Leu(1-Me)-DTrp-DTyr, [125I]-PD151242
PDEF(98-114)H105A 13832
peceleganan 13758 PL-5, V681
pegcetacoplan Approved drug Immunopharmacology Ligand 13826 APL-2, Empaveli®
pegdinetanib 10472 Angiocept®, BMS-844203, BMS844203, CT-322, CT322
pegfilgrastim Approved drug 6969 Neulasta®
peginesatide Approved drug 7447 AF37702, Hematide®, Omontys®
peginterferon alfa-2b Approved drug Immunopharmacology Ligand 7462 PegIntron®, Sylatron®
peginterferon beta-1a Approved drug Immunopharmacology Ligand 7637 interferon beta 1-alpha, PEG-INF-β-1a, Plegridy®
pegloticase Approved drug 7463 Krystexxa®, puricase
PEG40-NMU 7928
pegvisomant Approved drug 7485 B2036-PEG, Somavert®
pentagastrin Approved drug 870 AY-6608, ICI-50123, Peptavlon®
[Pen5]U-(4-11) (human) 2160 human [Pen5]-urotensin (4-11)
pepcan-12 9188
peptide 234 4012
peptide 5A 10588
peptide Cp40 [PMID: 25982307] Immunopharmacology Ligand 9220 peptide 14
peptide III-BTD 1696
peptide KLK2b(c1) 8484
peptide ligand 2 [PMID: 19055415] 8849 (cdGTyr(3-NO2)GBNc, LXY3
peptide 14 [PMID: 36580549] 12333
peptide 30 [PMID: 27019010] Immunopharmacology Ligand 9253
Peptide 5 [PMID: 28562585] 9588
peptide P19 [PMID: 15652659] 9163 [Ser11](N-CNP,C-ANP)pBNP(2-25)
petrelintide 13804 ZP-8396, ZP8396
pexiganan 14042 MSI-78
[(pF)Phe4]N/OFQ-(1-13)-NH2 1686 [(pF)Phe4]nociceptin(1-13)NH2, [(pF)Phe4]nociceptin/orphanin FQ(1-13)NH2, [(pF)Phe4]orphanin FQ(1-13)NH2, peptide 4a
PG-106 6546 PG 106, PG106
PG-901 1341 PG 901, PG901
PG 97-269 2268 [Acetyl-His1,D-Phe2,Lys15,Arg16,Leu17]VIP(3-7)/GRF(8-27)
PG 99-465 2272 Myr-His1[Lys12,Lys27,28,Gly29,30,Thr31]VIP, PG99-465
p-guanidinobenzoyl-MCH-(7-17) 1300
[Phaa1,D-Tyr(Et)2,Lys6,des-Gly9]AVP 2208
[Phaa1,D-Tyr(Et)2,Val4,Lys6,Tyr-NH28,des-Gly9]AVP 2209 TyrPhaa
[Phaa1,D-Tyr(Me)2,Arg6,Tyr-NH29]AVP 2210
[Phaa1,D-Tyr2,Val4,Arg6,Arg-NH29]AVP 2211
[Phe13]bombesin 615
[Phe8,ψ(CH2-NH)Arg9]BK 3846 [Phe8,ψ(CH2-NH)Arg9]bradykinin
[Phe3,Leu13]motilin (human) 1454
phelorphan 11655 deamino-norcysteinyl-L-phenylalanyl-L-phenylalanine
[Phe(Me)7]neurokinin B 2113 [MePhe7]NKB
[Phe3]OT 2178 [Phe3]oxytocin, oxypressin
[Phe23]PTH-(1-34) (human) 1807
[Phe13,Tyr19]MCH 1297 [Phe13,Tyr19]-melanin-concentrating hormone
[125I][Phe13,Tyr19]MCH Ligand is labelled Ligand is radioactive 3844 [Phe13,[125I]Tyr19]MCH, [Phe13,[125I]Tyr19]melanin-concentrating hormone
PHI  {Sp: Pig} 2273 peptide histidine-isoleucine
ω-phonetoxin-IIA 2540 ω-phonetoxin-2A, Neurotoxin Tx3-4, Omega-ctenitoxin-Pn3a, Phoneutriatoxin 3-4
[(3-Ph-Pr6), His7,D-Ala11,D-Pro13,ψ13-14),Phe14]bombesin-(6-14) 627
phrixotoxin 1 2582 PaTX 1
phrixotoxin 2 2583 κ-theraphotoxin-Ps1b, κ-TRTX-Ps1b, PaTX 2, PaTX2
phyllolitorin 6166 [Phe8]-phyllolitorin
phyllomedusin 2093
physalaemin 2094
Pi-hexatoxin-Hi1a 10306 π-Hi1a, π-HXTXHi1a, pi-Hi1a
Pi-theraphotoxin-Hm3a 10305 π-TRTX-Hm3a
PL017 1671 3-N-Me-Phe-morphiceptin, PL 017, PL-017
PL-3994 9067
[3H]PL017 Ligand is labelled Ligand is radioactive 3832 [3H]-PL017
platypus venom heptapeptide 1 13200
plecanatide Approved drug 9069 [3-glutamic acid(D>E)]human uroguanylin, SP-304, Trulance®
PLG0206 13313 WLBU2
PMX205 Immunopharmacology Ligand 5762 ALS-205, PMX 205, PMX-205
PMX53 579 Ac-(cyclo-2,6)-F-[OPdChaWR], PMX 53, PMX-53
ω-PnTx3-3 2541 ω-CNTX-Pn2a, ω-ctenitoxin-Pn2a, Neurotoxin Tx3-3, PnTx3-3
PnTx-3-6 2542 ω-CNTX-Pn4a, ω-ctenitoxin-Pn4a, Neurotoxin Tx3-6, PhAlpha-1-beta, PhAlpha-1-beta toxin
polybia-MP1 8861 MP1, MP-1
polymyxin B Approved drug 10338 Aerosporin®
Pomc (141-162) 10572
P4pal-10 10270 P4pal10
[PP1-17,Ala31,Aib32]NPY (human) 1561
[125I][PP1-17,Ala31,Aib32]NPY (human) Ligand is labelled Ligand is radioactive 1559
P2pal18S 6659 P2pal-18S
PP-(13-36) (human) 1550 human pancreatic polypeptide (13-36)
PP-(20-36) (human) 1552 human pancreatic polypeptide (20-36)
PP-(2-36) (human) 1551 human pancreatic polypeptide (2-36)
[125I]PP (human) Ligand is labelled Ligand is radioactive 3800 [125I]-pancreatic polypeptide, [125I]-PP
P32 [PMID: 27108698] 9384
P4 [PMID: 25923432] 8344
P59 [PMID: 27108698] 9385
P8 [PMID: 25923432] 8345
pralmorelin Approved drug 1092 GHRP-2, growth hormone-releasing peptide-2, KP 102
pramlintide Approved drug 7482 AC0137, Symlin®
PRL-2915 2066 PRL 2915
PRL-2970 2067 PRL 2970
pr1 nanopeptide 8263
[Pro3]GIP 3847 [Pro3]gastric inhibitory polypeptide
[Pro7]neurokinin B 2126
[Pro34]NPY 3848
[Pro34]PYY (human) 1546 human [Pro34] peptide tyrosine tyrosine, human [Pro34] peptide YY
[Pro9]SP 3849 [Pro9]substance P
protoxin II 7571 β/ω-theraphotoxin-Tp2a, β/ω-TRTX-Tp2a, protoxin-2, ProTx-2, ProTx-II, ProTx2, PT-II
PrP106-126 6244
[125I]PrRP31 Ligand is labelled Ligand is radioactive 4022 [125I]-PrRP31
PrRP-(24-31) (human) 1870 human prolactin-releasing peptide-24-31
[125I]PrRP-20 (human) Ligand is labelled Ligand is radioactive 1875 [125I]prolactin-releasing peptide-20
psalmotoxin 1 4292 PcTx1
[125I]psalmotoxin 1 Ligand is labelled Ligand is radioactive 4073 [125I]-PcTx1
pseudechetoxin 2354
PSMα3 6267
PTH-(1-34) (rat) 4449
PTHrP-(1-34) (human) 1822 parathyroid hormone-related peptide
PTHrP-(7-34) (human, rat, mouse) 1814 parathyroid hormone related peptide 7-34
PTHrP-(1-21)/PTH-(22-34) (human) 1788 hybrid of human PTHrP and human PTH
PTHrP-(1-20)/TIP-(23-39) (human) 1787
PWT2-N/OFQ 8865
PWT1-NPS 9167
[125I](Pyr1)apelin-13 Ligand is labelled Ligand is radioactive 601
[3H](Pyr1)[Met(0)11]-apelin-13 Ligand is labelled Ligand is radioactive 604
[125I]PYY Ligand is labelled Ligand is radioactive 1519 [125I]peptide tyrosine tyrosine, [125I]peptide YY
[125I]PYY-(3-36) (human) Ligand is labelled Ligand is radioactive 3802 [125I]-peptide YY(3-36), [125I]-PYY(3-36)
PYY-(13-36) (mouse, rat, pig) 1516 porcine peptide tyrosine tyrosine (13-36), porcine peptide YY (13-36), rat peptide tyrosine tyrosine (13-36), rat peptide YY (13-36)
PYY-(3-36) (pig) 1543 porcine peptide tyrosine tyrosine (3-36), porcine peptide YY (3-36)
[125I]PYY (pig) Ligand is labelled Ligand is radioactive 1520 [125I]pPYY
 
Q Back to top
QM107 13527
[125I]QRFP43 (human) Ligand is labelled Ligand is radioactive 3803 [125I-Tyr-32]-QRFP, [125I]-pyro-glutamylated arginine-amide peptide, [125I]-QRFP
Qu-SPX 11419
QWF Immunopharmacology Ligand 9568 Boc-Gln-D-Trp(CH0)-Phe-OBzl, Nα-[Nα-[Nα-(tert-butyloxycabonyl)-L-glutaminyl]-N1-formyl-D-tryptophyl-L-phenylalanine benzyl ester
 
R Back to top
R396 2118 R 396, R-396
R-486 2105 [Trp7,β-Ala8]neurokinin A(4-10), MEN 10295, R 486, R486
R-715 661 [Ac-Lys-[d-βNal7,Ile8]des-Arg9]bradykinin, R 715, R715
R-954 3906 AcOrn[Oic(2),(αMe)Phe(5),dβNal(7),Ile(8)]desArg(9)-bradykinin, R954
RAG8 10271
ranatensin 618
rasburicase Approved drug 7467 Elitek®, Fasturtec®, SR-29142
RB-400 900 RB 400, RB400
R3 B1-22R 11461
R3(BΔ23-27)R/I5 chimeric peptide 3907
R3(BΔ23-27)R/I5 chimeric peptide (B chain) 3909
relaxin  {Sp: Pig} 1992
relaxin  {Sp: Rhesus macaque} 1994
relaxin A chain  {Sp: Pig} 4438
relaxin A chain  {Sp: Rhesus macaque} 4440
relaxin B chain  {Sp: Pig} 4439
relaxin B chain  {Sp: Rhesus macaque} 4441
relaxin-3 B chain dimer 8337
[125I]relaxin-3-B/INSL5 A chimera Ligand is labelled Ligand is radioactive 3789 [125I]H3-B/INSL5 A chimera
[125I]relaxin-3 (human) Ligand is labelled Ligand is radioactive 1999 [125I]H3-relaxin (human)
[125I]relaxin (human) Ligand is labelled Ligand is radioactive 5398 [125I]H2 relaxin
[33P]relaxin (human) Ligand is labelled Ligand is radioactive 1991 [33P]H2 relaxin (human), [33P]Human gene 2 relaxin
reltecimod 13721 AB 103, AB103, p2TA
RES7011 3911 RES 701-1, RES-701-1
resokine 8736 aTyr 1920, HisRSN4, HRS(1-60)
retatrutide 13769
RF9 1486 1-Adamantanecarbonyl-RF-NH2
[125I]26RFa (human) Ligand is labelled Ligand is radioactive 10253
RgIA4 9472
R5-HIV-1 gp120 3910
Rhodei-litorin 6165 rohdeilitorin
rho-TIA 507 ρ-TIA, ρ-TIA conotoxin, 19-amino acid conopeptide, rho-conotoxin TIA
RhTx 12544 Tau-scoloptoxin04-Sm1a
ΔR3/I5 11916
R3/I5 1998 H3 relaxin B-chain/INSL5 A-chain chimera, H3 relaxin/INSL5 chimera, H3-B/INSL5 A chimera
rilonacept Approved drug Immunopharmacology Ligand 6790 Arcalyst®, IL-1 Trap, interleukin-1 Trap
R3/I5- SmBiT Ligand is labelled 11911
risuteganib 14194 ALG-1001, ALG1001, Luminate®
RLF-(A11-B10)-isopeptide amideA26 (xA11-B10) 11922
Ro 25-1392 2276 Ac-His1[Glu8,OCH3-Tyr10,Lys12,Nle17,Ala19,Asp25,Leu26,Lys27,28]VIP, Ro 251392, Ro251392
Ro 25-1553 2259 Ac-His1[Glu8,Lys12,Nle17,Ala19,Asp25,Leu26,Lys27,28,Gly29,30,Thr31]VIP-NH2(cyclo 21-25), Ro 251553, Ro-251553
romiplostim Approved drug Immunopharmacology Ligand 6974 MG531, Nplate®
rotigaptide 9214 Dipeptide 9f [PMID 19175320], GAP-134, ZP-123
R2R01 14150
RSLV-132 Immunopharmacology Ligand 10412 RSLV132
 
S Back to top
S36057 1294 S 36057, S-36057
S36077 1295 S 36077, S-36077
S36539 1308 S 36539, S-36539
S36540 1309 S 36540, S-36540
S36541 1310 S 36541, S-36541
S38151 1311 p-guanidinobenzoyl-[Des-Gly10]-MCH(7-17), S 38151, S-38151
[125I]S36057 Ligand is labelled Ligand is radioactive 1317
SAAP-148 13873 P148
sANP 5053 natriuretic peptide receptor/guanylyl cyclase A-selective agonist type A naturetic peptide (G9T, R11S, G16R)
sarafotoxin S6b 995
[125I]sarafotoxin S6b Ligand is labelled Ligand is radioactive 993
sarafotoxin S6c 1008 S6C, Sarafotoxin-C, SRTX-C
[Sar1,Ala8]Ang-II 6915
saralasin 598 P-113
[125I][Sar1]Ang-II Ligand is labelled Ligand is radioactive 6897
[Sar1,Cha4]Ang-II 6903
[Sar1,Cha8]Ang-II 6904
[125I][Sar1, D-Ala8]Ang II Ligand is labelled Ligand is radioactive 12299 125I-Sarcosine1, D-Alanine8-Angiotensin II
[Sar1, D-Ala12]galanin(1-16) 6082 [Sar1, D-Ala12]Gal(1-16), AR-M961
[Sar,D-Phe8,des-Arg9]bradykinin 643 [N-methylglycine,D-Phe8,des-Arg9]bradykinin, [sarcosine,D-Phe8,des-Arg9]bradykinin, Sar[DPhe8][des-Arg9]BK
[Sar1,Gly4,Gly8]Ang-II 6916
sargramostim Approved drug 7905 Leukine®
[Sar1,Ile8]Ang-II 6905
[125I][Sar1,Ile8]Ang-II Ligand is labelled Ligand is radioactive 6906
[Sar1,Ile4,Ile8]Ang-II 6914
[Sar9,Met(O2)11]SP 3850 [Sar9,Met(O2)11]substance P, [Sar9]substance P sulfone
SA10SC-RLX 12501
sauvagine 918
[125I]sauvagine (frog) Ligand is labelled Ligand is radioactive 916
sBmTX 3 2584 sBmTX3-delYP
SC-67655 Immunopharmacology Ligand 8889
(R)-SCH-23390 14202 (R)-SCH23390
sCKβ8-1 6251 CKβ8-1 (46-137)
α-scorpion toxin 2 2618 α-mammal toxin Lqh2, Lqh II, LqhII, LqTx-2
β-scorpion toxin Cn2 2632 β-mammal toxin Cn2, Toxin 2, Toxin II.9.2.2
β-scorpion toxin Css IV 2620 β-mammal toxin Css4, Css IV
β-scorpion toxin TiTXγ 2627 β-mammal/insect toxin Ts7, Tityustoxin VII, TsTX-VII
ScTx1 2576 κ-theraphotoxin-Sc1a, κ-TRTX-Sc1a, stromatoxin-1
SDF1 P2G 8536
SDF-1, 1-9[P2G] dimer 851 stromal cell-derived factor-1, N-terminal fragment analogue dimer
SE301 14149 SE-301
sea anemone toxin BDS-I 2578 antihypertensive protein BDS-1, blood depressing substance 1 (BDS-1)
secretin  {Sp: Pig} 1155
secretin-(5-27) (pig) 1156 secretin5-27 (porcine)
[125I]secretin (pig) Ligand is labelled Ligand is radioactive 1153
seglitide 2051 MK 678, MK-678, MK678
selepressin 11454 FE202158
semaglutide Approved drug 9724 NN-9535, NN9535, NNC0480 0389, Ozempic® (injectable semaglutide), Rybelsus® (oral semaglutide), Wegovy®
senktide 2127 suc[Asp6,MePhe3]SP(6-11), suc[Asp6,MePhe3]SP(6-11))
[3H]senktide Ligand is labelled Ligand is radioactive 3834 [3H]-senktide
septide 2095 [pGlu6,Pro9]substance P
seractide acetate Approved drug 6966
[Ser8]GnRH 1171 seabream GnRH
sermorelin Approved drug 6998 Geref®, sermorelin acetate
[Ser11](N-CNP,C-ANP)pBNP2-15 4853 P18
setmelanotide Approved drug 9272 BIM-22493, Imcivree®, IRC-022493, RM-493
SFKN-NH2 11226 NPS(1-4)NH2, peptide 3 [PMID: 28267583], PEPTIDE1{S.F.R.N.[am]}$$$$
SFKN-NH2 13997
SFLLRN-NH2 5361
SGTx1 7761 κ-theraphotoxin-Scg1a, κ-TRTX-Scg1a, toxin SGTx1
SHAAGtide 6275
ShK(L5) 2557 ShK-170
ShK Toxin 2549 potassium channel toxin ShK, Stichodactyla helianthus toxin
SHU9119 1325 (Ac-cyclo-[Nle4Asp5,D-Nal(2)7,Lys10]α-MSH-(4-10)-NH2), SHU 9119, SHU-9119
[125I]SHU9119 Ligand is labelled Ligand is radioactive 3804 [125I]-SHU9119
SI5α-b 11604
SiFA-Asn(AcNH-β-Glc)-PEG-Tyr3-octreotate 5634
SiFA-Asn(AcNH-β-Glc)-Tyr3-octreotate 5633
SKF-105494 2229 SK&F-105494, SKF 105494
SLIGKV-NH2 3740
SLIGRL-NH2 3741
slotoxin 2310 Potassium channel toxin α-KTx 1.11, SloTx
SNG001 Immunopharmacology Ligand 11129
SNX482 4315 SNX-482, toxin SNX-482
somatrogon Approved drug 12013 hGH-CTP, MOD-4023, MOD4023, Ngenla®, somatrogon-ghla
SOR-C13 12562
sovateltide Approved drug 3886 IRL 1620, IRL-1620, IRL2620, PMZ-1620, SPI-1620, Suc[Glu9,Ala11,15]ET-110-21, Tycamzzi®
spantide I 2096 [Arg1,Trp7,9,Leu11]substance P, [D-Arg1,D-Trp7,9,Leu11]-Substance P
spantide II 2097
[125I]spexin-1 Ligand is labelled Ligand is radioactive 11418
[125I]SP (human, mouse, rat) Ligand is labelled Ligand is radioactive 3805 [125I]-SP, [125I]-substance P
[3H]SP (human, mouse, rat) Ligand is labelled Ligand is radioactive 3835 [3H]-SP, [3H]-substance P
spinorphin 1026 LVVYPWT
SPR741 13250 NAB741
SQ007-5 8379
s-RhTx 12546
SsmTx-1 7764
sst3-ODN-8 2077 carbamoyl-des-AA1,2,4,5,12,13[d-Cys3,Tyr7,d-Agl8(Me,2-naphthoyl)]-somatostatin-14
[125I]Sta Ligand is labelled Ligand is radioactive 4850 [125I]-Sta
STM 434 8991
substance P-(4-11) 2099 substance P(4-11)
substance P-(6-11) 2100 substance P(6-11)
substance P-OMe 2101 SPME, SPOMe, substance P methylester
survodutide 13383 BI 456906, BI456906
 
T Back to top
T134 852
T140 853 [L-3-(2-naphthyl)-alanine3]-T134
T22 854 [Tyr5,12,Lys7]-polyphemusin II
tadekinig alfa Immunopharmacology Ligand 10077
TAK 044 3913 TAK-044, TAK044
TAK-448 10222 analogue 24 [PMID: 27589480], RVT-602, TAK448
taliglucerase alfa Approved drug 7444 Elelyso®, PRGCD
tamapin 2319 potassium channel toxin α-KTx 5.4
TamRLX Ligand is labelled 11462
taspoglutide 13315 BIM51077, ITM077, R1583
tatM2NX 11080 tat-M2NX
[tBaa1,D-Tyr(Et)2,Val4,Lys6,Arg-NH28,des-Gly9]AVP 2212
t-Boc-FLFLF 1030
t-Boc-Met-Leu-Phe 1029 tert-butoxycarbonyl (t-Boc) Met-Leu-Phe peptide
[tBu-D-Gly5]NPS 5812
[tBu-D-Gly5]NPS 12489
TC14012 Immunopharmacology Ligand 2902 TC 14012, TC-14012
T20(DP178) 5838 T20(DP178) [HIV-1 gp41 derived peptide]
T21/DP107 6245
teduglutide Approved drug Immunopharmacology Ligand 7049 ALX-0600, Gattex®, GLP2-2G, Revestive®
telitacicept Approved drug Immunopharmacology Ligand 11827 RC18, Tai'ai®
teriparatide Approved drug 4448 Forsteo®, Forteo®, PTH-(1-34) (human)
terlipressin Approved drug 11241 glycyl-glycyl-glycyl-L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparagyl-L-cysteinyl-L-prolyl-L-lysyl-glycinamide (4->9)-disulfide, Glypressin®, N-(N-(N-Glycylglycyl)glycyl)-8-L-lysinevasopressin, Terlivaz®, Variquel®
tertiapin-Q 2383 TPN(Q)
[125I]tertiapin Y1/K12/Q13 Ligand is labelled Ligand is radioactive 2382
tesamorelin Approved drug 6959 (3E)-hex-3-enoylsomatoliberin, Egrifta®, TH9507
tethered chemerin 9 Immunopharmacology Ligand 9784
β3-tetrapeptide 2078
TFLLR-NH2 3742 PEPTIDE1{T.F.L.L.R.[am]}$$$$, Thr-Phe-Leu-Leu-Arg-amide
TFRGAP-NH2 5360
TG-0205221 PDB Ligand 11176 Cbz-Thr(tBu)-Cha-Ala(((S)-2-oxopyrrolidin-3-yl))-ol, N-benzyloxycarbonyl-O3-tert-butyl-L-threonyl-3-cyclohexyl-L-alanyl-3-((S)-2-oxopyrrolidin-3-yl)-L-alaninol, TG0205221
THG213.29 5860
[Thi5,8,D-Phe7]bradykinin 678
Thr10contulakin-G 1573
[Thr4,Gly7]OT 2179 [Thr4,Gly7]oxytocin
timtraxanib 11673 AVI-3207, AVI3207, N2-acetyl-L-arginyl-L-leucyl-L-tyrosyl-L-glutamic acid
TIP39-(3-39) (human/bovine) 1816 human/bovine tuberoinfundibular peptide 3-39
TIP39-(7-39) (human/bovine) 1827 human/bovine tuberoinfundibular peptide 7-39
TIP39-(9-39) (human/bovine) 1818 human/bovine tuberoinfundibular peptide 9-39
TIP39-(7-39) (mouse) 1828 mouse tuberoinfundibular peptide 7-39
tirzepatide Approved drug 11429 LY-3298176, LY3298176, Mounjaro®, Zepbound®
T20K 13239
TK-HR peptide 13042 tachykinin-HR
tolyacetyl-c[DCys-Apa-DTrp-Orn-Val-Cys]-His-amide 2166
toxin BmP09 2306 B. martensi Karsch toxin, beta-toxin BmKAs1, BmK activator of skeletal-muscle ryanodine receptor
TP0556351 12057 compound 9 [PMID: 35687819], TP-0556351
TP508 9284 Chrysalin
trans-cinnamoyl-LIGRLO [N-[3H]propionyl]-NH2 Ligand is labelled Ligand is radioactive 3914
trebananib 8414 2xCon4[C], AMG-386, TN8-Con4
[3H]TRH (human, mouse, rat) Ligand is labelled Ligand is radioactive 3836 [3H]-thyrotropin-releasing hormone, [3H]-TRH
Tri-DAP 9507 L-Ala-γ-D-Glu-mDAP
[125I]triptorelin Ligand is labelled Ligand is radioactive 1168 [125I][D-Trp6]GnRH
triptorelin Approved drug 1177 CL 118532, CL-118532, Decapeptyl®, Pamorelin®, Trelstar®, Triptodur®
trofinetide Approved drug 12482 ACP-2566, analogue 4 [PMID: 15837309], Daybue®, glycyl-alpha-methyl-L-prolyl-L-glutamic acid, NNZ-2566, NNZ2566
[Trp7, β-Ala8] neurokinin A-(4-10) 5782
[Trp8]GnRH 1172 frog GnRH
Trp11-neurotensin 1585
[Trp23]PTHrP-(1-36) (human) 1809
trptorelix-1 3916 Trp-1
[Trp23,Tyr36]PTHrP-(1-36)-NH2 (human) 1808
TRV023 11943 TRV 023, TRV-023
TRV026 11944 TRV 026, TRV-026
TRV027 6902 TRV 120027, TRV-027, TRV-120027, TRV120027
[125I]TSH (human) Ligand is labelled Ligand is radioactive 3806 [125I]-thyroid-stimulating hormone, [125I]-thyrotropin, [125I]-TSH
[125I]Tyr-Ala-hexarelin Ligand is labelled Ligand is radioactive 1095
[125I][Tyr4]bombesin Ligand is labelled Ligand is radioactive 623 [125I-Tyr4]BN
[125I][Tyr8]bradykinin Ligand is labelled Ligand is radioactive 3765 [125I]-[Tyr8]-bradykinin, [125I]-[Tyr8]BK, [125I][Tyr8]BK
[Tyr8]bradykinin 671 [Tyr8]BK
Tyr0α-CGRP (human) 692 Tyr0α-calcitonin gene-related peptide (human)
[125I]Tyr0-CRF (human, rat, mouse) Ligand is labelled Ligand is radioactive 914 [125I]-Tyr0-corticotropin
[125I]Tyr10-CST14 Ligand is labelled Ligand is radioactive 2024 [125I]-[Tyr10]CST-14, [125I]Tyr10-cortistatin14
[125I][Tyr5,DAla6,NMeLeu7,Pro9-NEt]GnRH Ligand is labelled Ligand is radioactive 1165
[125I][Tyr11]des-Br-NPB-23 Ligand is labelled Ligand is radioactive 1498 [125I][Tyr11]des-Br-neuropeptide B-23
[125I]Tyr4-des-octanoyl-ghrelin Ligand is labelled Ligand is radioactive 3810 [125I]-Tyr4-des-octanoyl-ghrelin
[125I][Tyr26]galanin (human) Ligand is labelled Ligand is radioactive 5391 [125I]-[Tyr26]galanin
[125I][Tyr26]galanin (pig) Ligand is labelled Ligand is radioactive 6117
[125I][Tyr26]galanin (rat/mouse) Ligand is labelled Ligand is radioactive 5390 [125I]-[Tyr26]galanin
[125I][Tyr4]ghrelin (human) Ligand is labelled Ligand is radioactive 1096 [125I-Tyr4]-ghrelin, [125I-Tyr4]ghrelin
[Tyr34]GLP-2 (human) 1145 human [Tyr34] glucagon-like peptide 2
[Tyr8]GnRH 1173
[125I]Tyr45-kisspeptin-15 Ligand is labelled Ligand is radioactive 1280 [125I-Tyr45]-KP15, [125I-Tyr45]kisspeptin-15, [125I-Tyr45]KP-15
[3H]Tyr14-N/OFQ Ligand is labelled Ligand is radioactive 1687 [3H]14-Tyr-N/OFQ, [3H]14-Tyr-nociceptin, [3H]14-Tyr-nociceptin/orphanin FQ, [3H]14-Tyr-orphanin FQ
[125I]Tyr10NPS (human) Ligand is labelled Ligand is radioactive 1493 human [125I]Tyr10-neuropeptide S
Tyr3-octreotide 5649 SMS 204,090, TOC, Tyr3-SMS 201,995
[Tyr34]PTH-(1-34) (human) 1810
[Tyr34]PTH-(1-34)-NH2 (human) 1811
[Tyr34]PTH-(3-34)-NH2 (human) 1812 [Tyr34]-PTH 3-34-NH2
[Tyr36]-PTHrP-(1-36) amide (human) 1813 [Tyr36]-PTHrP 1-36 amide
[125I]Tyr0-sauvagine Ligand is labelled Ligand is radioactive 5389 [125I]-Tyr0-sauvagine
[125I](Tyr10)secretin-27 (rat) Ligand is labelled Ligand is radioactive 3759 [125I]-(Tyr10)secretin
[125I]Tyr3 SMS 201-995 Ligand is labelled Ligand is radioactive 2062 [125I][Tyr3]octreotide
[125I]Tyr11-SRIF-14 Ligand is labelled Ligand is radioactive 2060 [125I]Tyr11-SS-14
[125I]Tyr7-Sst3-ODN-8 Ligand is labelled Ligand is radioactive 2075
[125I][Tyr3,Thr8]octreotide Ligand is labelled Ligand is radioactive 5630 [125I]-TOCA, [125I]-Tyr3-octreotate
 
U Back to top
UFP-101 1694 [Nphe1,Arg14,Lys15]N/OFQ-NH2, [Nphe1,Arg14,Lys15]nociceptin-NH2, UFP 101, UFP101
UFP-102 1685 [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2, UFP 102, UFP102
UFP-112 3917 [(pF)Phe4Aib7Arg14Lys15]N/OFQ-NH2, UFP 112, UFP112
Ugr 9-1 11475 π-AnmTX Ugr 9a-1
[125I]U-II (human) Ligand is labelled Ligand is radioactive 2158 human [125I-Tyr9] urotensin-II, human [125I] urotensin-II
U-II-(4-11) (human) 2152 human urotensin-II (4-11)
ularitide 8446 ESP-305
uPar fragment 6249 D2D388-274, uPAR(88-274)
urantide 2167 [Pen5,DTrp7,Orn8]U-II (4-11) (human)
[125I]urocortin 1 (mouse, rat) Ligand is labelled Ligand is radioactive 917
Urolinin 9441
urotensin 1 (fish) 922
 
V Back to top
[Val4]AVP 2180 VDAVP, 4-Val-argipressin
valspodar 11745 3'-keto-Bmt(1)-Val(2)-cyclosporin A, Amdray®, PSC-833, PSC833, SDZ PSC 833, SDZ PSC833, SDZ-PSC-833
vanillotoxin-1 5542 tau/kappa-theraphotoxin-Pc1a, tau/kappa-TRTX-Pc1a, VaTx1
vanillotoxin-2 5543 tau-theraphotoxin-Pc1b, tau-TRTX-Pc2a, VaTx2
vanillotoxin-3 5544 tau-theraphotoxin-Pc1c, tau-TRTX-Pc1c, VaTx3
vapreotide Approved drug 2054 BMY 41606, CCRIS 6495, RC 160, RC-160, Sanvar®, vapreotide acetate
variant MCH 1302 variant melanin-concentraing hormone
vCCL4 774 viral CCL4
vCXCL1 8496
velaglucerase alfa Approved drug 7464 EC 3.2.1.45, VPRIV®
veldoreotide 8487 COR-005, DG3173, PTR-3173, somatoprim
[125I]VIP (human, mouse, rat) Ligand is labelled Ligand is radioactive 2277 [125I]-VIP, [125I]vasoactive intestinal peptide
Vm24 Immunopharmacology Ligand 10050 α-KTx 23.1
vMCC-I 816 MCV MC148R
vMIP-I 815 HHV8 vMIP-I, viral macrophage inflammatory protein
vMIP-II 768 vMIP-II, viral macrophage inflammatory protein-II
vMIP-III 4359 HHV8 vMIP-III, KSHV vMIP-III
voclosporin Approved drug Immunopharmacology Ligand 11388 1,11-anhydro[L-alanyl-D-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl- N-methyl-L-valyl-[(2S,3R,4R,6E)-3-hydroxy-4-methyl- 2-(methylamino)nona-6,8-dienoyl][(2S)-2-aminobutanoyl]- N-methylglycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucine], E-ISA247, ISA(TX)247, ISA-247, ISA247, ISATX247, Lupkynis®, R 1524, R-1524, R1524
vosoritide Approved drug 9068 BMN 111, BMN-111, Voxzogo®
V3 peptide 6248
 
W Back to top
waglerin-1 3984
wFw-Isn-NH2 5869
WKYMVm Immunopharmacology Ligand 1048 Trp-Lys-Tyr-Met-Val-[D]Met, WKYMVM
WRWWWW Immunopharmacology Ligand 1040 WRW4
WWGKKYRASKLGLAR 5760
 
X Back to top
[125I]XCL1 (human) Ligand is labelled Ligand is radioactive 857 [125I]ATAC, [125I]lymphotactin, [125I]SCM-1α
X4-HIV-1 gp120 3919 X4 human immunodeficiency virus type 1 gp120
XMP-629 14069 XOMA-629
 
Y Back to top
YH35324 Immunopharmacology Ligand 13448 IgETRAP, YH-35324
YJ34 8722
Y-KE88 5641
[125I]Y-RFRP-3 Ligand is labelled Ligand is radioactive 1484 [125I]YVP
Y-RFRP-3 1482 YVP
YSFKPMPLaR 5776 C5a65-74Y65,F67,P69,P71,D-Ala73
 
Z Back to top
Z-Arg-Leu-Val-Agly-Ile-Val-OMe 6534
Z-AVLD-FMK 11712
Z-DEVD-FMK 5294 benzyloxycarbonyl-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-fluoromethylketone
Z-DQMD-FMK 5295 benzyloxycarbonyl-Asp(OMe)-Gln-Met-Asp(OMe)-fluoromethylketone
Z-FA-FMK Immunopharmacology Ligand 11257 MDL 201053, MDL-201053, MDL201053, Z-Phe-DL-Ala-fluoromethylketone, ZFA-fmk
ziconotide Approved drug 2536 ω-conotoxin MVIIA, Prialt®, SNX-111
Z-IETD-FMK 5296
zilucoplan Approved drug Immunopharmacology Ligand 10404 RA-101495, RA101495, Zilbrysq®
Z-LEHD-FMK 5298 benzyloxycarbonyl-Leu-Glu(OMe)-His-Asp(OMe)-fluoromethylketone
zolucatetide 14191
Z-VDVAD-FMK 5299 benzyloxycarbonyl-Val-Asp(OMe)-Val-Ala-Asp(OMe)-fluoromethylketone
Z-VEID-FMK 5300 benzyloxycarbonyl-Val-Glu(OMe)-Ile-Asp(OMe)-fluoromethylketone
Z-WEHD-FMK 5301 benzyloxycarbonyl-Trp-Glu(OMe)-His-Asp(OMe)-fluoromethylketone
zyklophin 9193
Z-YVAD-FMK 5302 benzyloxycarbonyl-Tyr-Val-Ala-Asp(OMe)-fluoromethylketone, caspase-1 Inhibitor VI
ZZL-7 12316 Ac-Ala-Val-Ome